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1 INTRODUCTION 
Alphaviruses (family Togaviridae) cycle between susceptible vectors and verte-
brate hosts in nature. Although their evolutionary origin has not been con-
firmed, some sequence analysis suggests that alphaviruses may initially have 
arisen from a parasite-borne plant virus and that the mobility of the vector con-
tributed to the divergence of the genus. At least two transoceanic inductions of 
alphaviruses must have occurred in the past [1]. 
Since their isolation, alphaviruses have served as a model system for study-
ing the structure and functions of enveloped viruses of animals. Semliki Forest 
virus (SFV) was among the first alphaviruses to be discovered, and SFV was 
isolated in 1942 from mosquitoes in Uganda [2]. Other alphaviruses, including 
Sindbis virus (SINV) and Chikungunya virus (CHIKV), have been subsequently 
isolated from mosquitoes [3] and mammals [4]. 
According to their geographic distribution, alphaviruses have been divided 
historically into Old World and New World viruses. Old World alphaviruses, 
including SFV, SINV and CHIKV, primarily cause fever and rash but can also 
induce arthritic symptoms and severe joint pain. New World alphaviruses, in-
cluding Venezuelan Equine Encephalitis virus (VEEV), tend to cause encepha-
litis [1]. The laboratory strains of SFV and SINV are non-pathogenic to hu-
mans; however, these viruses, as well as a number of other alphaviruses, are 
lethal to mice at a certain age [5–7]. Several strains and isolates of a single vi-
rus, the virulence of which can differ significantly, have been discovered. For 
example, in contrast to the widely used laboratory SFV4 strain [8], the replica-
tion of SFV strain A7 that was isolated from Mozambique mosquitoes in 1959 
[5] is restricted by the age of neurons [9]. Very few amino acid (aa) substitu-
tions are responsible for the more neuroinvasive phenotype of SFV4 [10]. In 
addition, the virulence of alphaviruses depends on their ability to overcome the 
host’s innate immune response. Interferon (IFN)-competent animals can limit 
the spread of SFV and protect some organs and tissues from being infected [11]. 
Thus, both genetic determinants of the virus and the competent IFN response of 
the host contribute to the outcome of the alphaviral infection. 
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2. REVIEW OF THE LITERATURE 
2.1 An overview of alphaviruses 
SFV is one of the most well studied alphaviruses, mainly due to the simplicity 
of its genome, its high biosafety [12] and its significant potential for use in bio-
technology. Like all alphaviruses, SFV is a positive-strand RNA virus. Its ge-
nome is approximately 11.5 kb in length, is capped at the 5’ end, and has a 
poly(A) tail at the 3’ end [13]. The SFV genome encodes four nonstructural (ns) 
proteins (nsP1-4), the viral components of the viral replicase, and five or six 
structural proteins that are needed for the formation of the capsid and the glyco-
protein-containing envelope [14]. The structural proteins are expressed from the 
subgenomic (sg) RNA that is synthesized from the sg promoter. In contrast, ns-
polyprotein P1234 or P123 and P1234 polyproteins (for some SFV strains such 
as A7 [10]) are directly translated from the genome. Two polyproteins are 
synthesized for the viruses and strains, which have a leaky in-frame stop codon 
present between the nsP3 and nsP4 coding regions. Gradual autocatalytic cleav-
ages in the ns-polyprotein are performed by the nsP2 protein or the nsP2 region 
of ns-polyproteins [15,16]. In early infection, P1234 is autocatalytically cleaved 
to P123 and nsP4 [17]. This complex synthesizes the complementary negative-
strand RNA and is therefore named an early replication complex [14,18]. 
Subsequent cleavages in the ns-polyprotein provide the late replicase complex 
that consists of individual nsPs. This complex is prone to synthesize RNA of 
positive polarity – new genomic RNA and sg RNAs. The late replicase complex 
is generally incapable of synthesizing RNA of negative polarity; thus, due to 
changes in the ns-polyprotein processing pattern the synthesis of negative-
strand RNA stops at the late stages of alphavirus infection [19]. Structural gene 
products do not participate in replication and can be replaced with any sequence 
of interest up to 9 kb in length. This property has been used for the development 
of SFV-based replicon vectors [8].  
SFV infects different vertebrate and insect cell lines. In vertebrate cells, the 
SFV infection leads to prominent changes in cellular structures and inhibition of 
different host biosynthesis processes, and it results in cell death by apoptosis 
[20,21]. This type of infection reflects in vivo infections in vertebrates that are 
characterized by high viremia and can lead to the death of the host [22]. How-
ever, infection in mosquito vectors is quite different. In mosquitoes, the infec-
tion starts in the midgut of the insect and then spreads to other organs. After the 
virus reaches the salivary glands, the infected vector begins spreading the virus 
with each blood meal [23,24]. Infection in the mosquito is persistent and does 
not have a major impact on the viability of the vector. In addition, only limited 
cell death, mostly occurring during the early phase of infection, can be observed 
in alphavirus-infected, cultivated mosquito cells [25]. The early phase of infec-
tion in mosquito cells is relatively similar to the infection in vertebrate cells; 
this phase is characterized by the active production of progeny virions [26]. 
After this phase, the persistent infection is established [25]. During alphaviral 
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infection in invertebrate cells, a large amount of defective interfering (DI) RNA 
genomes are synthesized [27,28]; the DI RNA genomes may have a role in the 
establishment of the persistent infection. However, other studies have identified 
RNA interference (RNAi) as one of the most prominent antiviral mechanisms 
used by insects and insect cells to restrict alphavirus infection [29]. Other studies 
have clearly indicated that RNAi does not represent the only defense against 
alphaviruses, and some other mechanisms protect insects from alphavirus in-
fection equally well [28,30–32]. As the infection of insect cells is restricted by 
multiple different antiviral mechanisms, alphaviruses must be fit to infect these 
cells. Indeed, mutations in alphaviral replicase proteins that affect viral replication 
in vertebrate cells minimally or not at all significantly reduce the infectivity in 
insect cells or cause a temperature-sensitive phenotype of the virus [14,33–35]. 
Thus, the requirements for efficient replication in mosquito and vertebrate cells 
are diverse, and viral nsPs may have different roles in distinct host cell types. 
 
 
2.2 Alphaviral infection cycle 
Virion 
The alphaviral virion is a spherical particle that is approximately 68 nm in di-
ameter [36]. The virion has a T=4 type of geometry [37,38]. Thus, the genomic 
RNA is covered by a core of 240 molecules of capsid protein (C) that are orga-
nized in pentameric and hexameric structures. The core containing the virus 
genome (nucleocapsid) is surrounded by a lipid bilayer derived from the host 
cell membrane [37,39]. The lipid bilayer itself is further covered by a glycopro-
tein lattice that almost completely hides the membrane, and distinct glycopro-
tein spikes that protrude from the particle can be observed [40]. The spikes are 
composed of all three structural glycoproteins (E3, E2 and E1) in an SFV virion 
[41,42] or only E2 and E1 in the virions of most other alphaviruses [36,39] and 
are hollow on the inside [40]. One spike contacts a single monomer of the cap-
sid protein [39,43], and this contact occurs via the cytoplasmic domain [41] of 
the E2 protein [44]. This mechanism ensures a 1:1 molar ratio between the cap-
sid proteins and the E1 and E2 glycoproteins [37]. Three glycoprotein spikes 
form a trimeric complex. Thus, in total, 240 copies of each glycoprotein, which 
are organized into 80 heterotrimeric complexes, are present in each virion.  
 
Binding and entry 
Alphaviruses have a broad host range and use a number of different cellular 
receptors. The identity of the receptors depends on the host and tissue type to be 
infected. Receptors that enable the infection of a certain host are not always 
involved in infecting other hosts. In addition, alphaviruses may use several 
receptors in a single cell line. Therefore, the identity of alphaviral receptors 
remains unclear. For SFV, class I major histocompatibility antigens are thought 
to be involved in the infection of human and murine cells [45]. SINV can use 
laminin receptors for promoting its infection in mammalian and insect cells 
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[46]. However, attachment to C-type lectins [47], heparan sulphate [48,49] and 
a divalent metal ion transporter (natural resistance-associated macrophage pro-
tein) have also been demonstrated [50]. In chicken cells, SINV can use a 63 
kDa protein for entering the cells [51]. The viral factor (anti-receptor) needed 
for efficient binding on the plasma membrane of the cell is the glycoprotein E2 
[52,53]. 
After binding to the receptor, alphaviruses enter the cell by clathrin-depend-
ent endocytosis (Fig. 1). The virus is engulfed into endocytic vesicles [54] and 
fuses its membrane with vesicle membranes to release its nucleocapsid into the 
cytosol. This process is aided by a decrease in pH that occurs as endocytic vesi-
cles mature; however, the success of the fusion also depends on the lipid com-
position of the endosome membrane. Cholesterol has been shown to mediate 
viral binding to target membranes, while sphingolipids assist the actual fusion 
event [55,56]. The participation of monovalent cations has also been observed 
[57]. When these molecules are present in the target membrane, a pH lower than 
6 [56,58] induces membrane fusion that is completed within less than one mi-
nute at 37 °C [40,59].  
The fusion mechanism is relatively well understood. In response to acidic 
conditions, the spikes (E1:E2 heterodimers) in the virus envelope dissociate 
[60]. The E2 portion moves away from the center of the trimeric complex, 
whereas E1 slides toward the center, the entire spike region elongates [40], and 
E1 forms homotrimers [61]. The fusion peptide residing in E1 becomes exposed 
[59,61], and the membranes are fused [62]. The exact details of these processes 
have been revealed by using the three-dimensional structure of alphaviral gly-
coprotein envelope [63,64]. 
Through membrane fusion, the nucleocapsid is released into the cytosol, 
where the RNA is uncoated due to the contacts between the C protein and ribo-
somes [65–67]. The C proteins remain associated with ribosomes, whereas viral 
RNA is engaged in translation and becomes associated with cellular membranes 
[65]. C protein cleavage may also contribute to the uncoating of RNA in the 
cytosol [68]. 
Thus, the initial steps of infection in vertebrate cells are relatively well de-
scribed. Nevertheless, other mechanisms of entry may also exist [69]. As is the 
case with many aspects of alphavirus infection, their binding and entry into 
insect cells are poorly understood. 
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Figure 1. Schematic representation of the alphavirus infection cycle. Modified from [246], 
with permission. Alphavirus infection begins by the binding of a virion to a cellular receptor and 
entrance into the cell by receptor-mediated endocytosis. The endosomes fuse with lysosomes, re-
sulting in a decrease in pH. The low pH induces a membrane fusion event, and the nucleocapsid is 
released into the cytoplasm. Upon nucleocapsid disassembly, the viral genome is released into the 
cytoplasm and becomes translated by ribosomes. The cleavage products of ns-polyprotein P1234 
form a virus-specific part of the alphavirus replicase. The synthesis of negative-strand RNA and 
new positive-strand RNAs is associated with the cytoplasmic membranes, which are represented 
primarily by lysosomal membranes in the late stage of infection. After the synthesis and cleavage 
of the structural polyprotein, the viral glycoproteins are transported to the plasma membrane, 
whereas capsid protein surrounds the newly synthesized viral genomes. The formed nucleo-
capsids are transported to the plasma membrane, where the capsid protein associates with the 
cytoplasmic tails of the E2 glycoproteins. The binding event triggers the budding of the virion. 
 
 
Requirements for replication 
The RNA synthesis of alphaviruses is asymmetric and temporarily regulated 
[19]. Three types of viral RNAs are present in an alphavirus-infected cell: the 
genomic RNA of positive polarity (42S for SFV), the corresponding chain of 
negative polarity and the sg RNA with positive polarity [70]. Only the genome 
length RNAs are associated with the replication process. The replication of 
alphaviruses occurs in association with cellular membranes [71] and will be 
addressed in detail in later chapters. 
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The SFV genomic and sg RNAs have a 5’ terminal cap structure [72] and a 
poly(A) tail [70]. These elements are required for their stability and translation 
but are also essential for efficient replication and transcription of the virus ge-
nome. Three untranslated regions (UTR) are found in alphavirus genomes: one at 
each end of the genome and one in the junction region between the structural and 
ns-polyprotein coding sequences. Inside the UTRs, two conserved sequence 
elements (CSE) have been identified. In total, the alphavirus genome contains 
four CSEs that are numbered according to their position from the 5’ end of the 
genome. One of these CSEs (CSE2) is located inside the coding sequence of 
nsP1, and another (CSE3) is typically located at the 3’ part of the coding sequence 
of nsP4 (Fig. 2). These elements interact with host and viral proteins to ensure the 
correct replication and transcription of viral RNA. CSE1 is 40 nt in length and has 
a stem-loop structure [73]. This element is required for initiating both negative- 
and positive-strand RNA synthesis and is considered to be the core promoter for 
RNA synthesis [74]. CSE2 is located approximately 150 nt from the 5’ end of the 
genome. CSE2 is 51 nt in length (hence, this element is also called the 51 bp 
conserved sequence element), and its secondary structure contains two stem-loops 
[73]. This element enhances negative- and positive-strand RNA synthesis but is 
not absolutely required for virus replication in mammalian cells [74]. 
Transcription of the sg RNA is initiated on the sg promoter, which contains CSE3 
that spans from 19 nt upstream to 2 nt downstream of the starting site of sg RNA 
synthesis. However, the minimal essential sg promoter is somewhat longer (-19 to 
+5) [75]. The final conserved element is CSE4, which directly precedes the 
poly(A) tract. CSE4 is located in the 3’ UTR of the genome and is required for 
the initiation of negative-strand RNA synthesis [76,77]. A 19-nt portion of the 
element is shown to be required for defective interfering RNA replication [77]. 
During negative-strand synthesis, CSE4 and CSE1 are brought into contact by 
host cell proteins [74]. In several alphaviruses, an AU-rich segment and a 
repeating sequence element are present upstream of CSE4. In contrast to CSEs, 
this region is rather tolerant to smaller modifications that affect virus viability 
only in certain cell types [30]. Therefore, the region preceding CSE4 is thought to 
affect the host specificity of the alphavirus. 
 
 
 
Figure 2. Alphavirus genome and location of sequences required for replication, gene ex-
pression and virion formation. The genomic RNA is capped at the 5’ end and polyadenylated at 
the 3’ end. The CSEs in the figure are represented by black boxes and numbers. PS indicates the 
packaging signal residing in the SFV nsP2 coding region. The asterisk represents the in-frame 
stop codon present in some SFV strains and in genomes of most other alphaviruses. The arrow 
represents the start site of the sg promoter; CSE-3 resides inside the sg promoter element. A trans-
lation enhancer element (Enh) is located in a region encoding the N-terminus of the capsid pro-
tein. R-AU represents the repeated and AU-rich sequences hypothesized to bind host specific fac-
tors. The sizes in the figure are not proportional to their actual sizes in the virus genome to allow 
a clearer presentation of the short CSEs. 
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Aside from the elements required for replication, additional RNA sequences 
that are important for alphavirus infection have been described. For example, 
the first 102 nt from the capsid protein-encoding region comprise a translation 
enhancer for SFV [78]. This element represents a highly stable RNA secondary 
structure that is not found in the genomes of all alphaviruses. Another important 
element is the packaging signal that contains several stem-loop structures and 
resides in the nsP1 or nsP2 coding region in SINV or SFV, respectively [79,80]. 
 
Virion formation and budding 
Translation of the sg RNA begins in the cytoplasm of an infected cell using free 
ribosomes [81]. The first protein encoded by the sg RNA is the C protein, which 
is cleaved autoproteolytically from the structural polyprotein immediately after 
its synthesis is completed [82]. The remaining structural polyprotein is the 
precursor for glycoproteins. While still being translated, this polyprotein is 
translocated to the endoplasmic reticulum, where it is inserted into the mem-
brane according to the signal sequences within it [83–85] and processed by a 
signal peptidase [84,86] into three parts: p62 (the precursor of E3 and E2), 6K 
and E1. The glycoproteins are heavily modified by glycosylation [87] and pal-
mitoylated [88]. Either before or during transport to the Golgi apparatus, pri-
mary spike complexes between the p62-E1 proteins are formed [89] In the 
trans-Golgi network, the last structural polyprotein precursor, p62, is cleaved 
into E3 and E2 [90]. This cleavage that is performed by a cellular furin protease 
[91] destabilizes the structure of the spikes. Once introduced into the virion 
membrane, the spikes can mediate the fusion between the virion membrane and 
endosomal membranes. This process is essential for infecting the next cell [92]. 
Subsequently, the mature glycoprotein complexes are inserted into the plasma 
membrane via exocytosis [93]. 
The formation of nucleocapsids that contain genomic RNA and capsid pro-
teins, glycoprotein processing and transport occur simultaneously. Most alpha-
viruses, including SINV, have a conserved secondary RNA structure that acts as 
the packaging signal located in the nsP1 coding region [79,94]. The correspond-
ing region in SFV and CHIKV does not have any effect on genome encapsida-
tion [94]. Rather, the packaging signal for these viruses is represented by the 
conserved RNA secondary structure located in the nsP2 coding region [80]. 
Because the packaging signal resides in the ns-polyprotein coding region in 
both cases, the sg RNA is not included in the virions. C protein dimerization is 
promoted by RNA folding [95]. The packaging signal interacts with a 68 aa 
lysine and arginine-rich fragment residing in the N-terminal region of the capsid 
protein [79]. The resulting capsid protein-genomic RNA complex forms a T=4 
nucleocapsid that moves to the cell membrane, where the capsid protein inter-
acts with the long cytoplasmic tail of the E2 protein [96]. 
For SFV, the usual path of exit from infected vertebrate cells is budding 
from the plasma membrane [93]. The RNA-containing nucleocapsid needs to 
contact E2 directly to begin the budding process [96,97]. Virion exit from the 
infected cell has been shown to depend on cholesterol. Cells depleted of cho-
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lesterol produce remarkably less viral particles than unmodified cells [98,99]. In 
addition, the interactions between E1/E2 and their transmembrane domains 
strongly affect budding efficiency [100]. 
Similar to the entry process, possible alternatives to this general exit path-
way exist. Primarily, the formation of alphavirus virions in insect cells does not 
occur only on the plasma membrane. Instead, formation can occur on cytoplas-
mic membranes as well, and matured virions are then released by exocytosis 
[101]. A similar process may also occur in some vertebrate cells, such as neu-
rons. 
 
 
2.3 Individual nonstructural proteins 
Although the primary role of the alphaviral ns-proteins is mediating RNA repli-
cation and transcription, a large fraction of the synthesized ns-proteins does not 
localize in the replication complexes. Instead, significant amounts of these pro-
teins are dispersed throughout the entire cell. Each of these proteins has a dis-
tinct location, and these proteins conduct distinct functions apart from their 
roles in RNA replication [102]. Subcellular locations of the ns-proteins outside 
the replicase complexes are summarized in table 1. 
 
 
Table 1. Subcellular locations of the ns-proteins in an infected cell 
Protein Known localization outside replicase complexes 
nsP1 Filopodia-like extensions, plasma membrane 
nsP2 Nucleus, diffusely in cytoplasm 
nsP3 In punctate structures in cytoplasm 
nsP4 In punctate structures in cytoplasm before rapid degradation 
 
 
NsP1 of SFV consists of 537 aa residues and has a molecular mass of 64 kDa 
[103]. This protein has been shown to participate in negative-strand RNA 
synthesis [104–107]. NsP1 is also important for capping viral genomic and sg 
RNAs due to its guanine-7-methyltransferase [108] and guanylyltransferase 
activities [109,110]. Capping is vital for the virus because mutations that abol-
ish the enzymatic activities required for the capping function render the corre-
sponding RNA genomes non-infectious [111]. NsP1 is also thought to partici-
pate in sg RNA synthesis, as stable expression of nsP1 in a transgenic host cell 
has been shown to cause delayed accumulation of structural proteins [112]. 
NsP1 is the only ns-protein that interacts directly and strongly with cellular 
membranes [113,114], more specifically with membranous anionic phospholip-
ids [115]. When expressed in a cell in the absence of other ns-proteins, nsP1 
localizes to the plasma membrane, causing the induction of filopodia-like 
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structures void of F-actin [114,116]. Some quantities of the transmembrane 
protein CD44 and the plasma membrane protein ezrin have also been found on 
the filopodia in addition to nsP1 [116]. The filopodia-like structures are also 
characteristic of SFV-infected cells; however, the significance of these struc-
tures is not known. In contrast, when nsP1 is expressed in the form of uncleava-
ble P123 or P1234 polyprotein, nsP1 directs (together with nsP3) the localiza-
tion of the ns-polyprotein to cytoplasmic membranes [117]. 
The binding of nsP1 to membranes occurs in two steps: first, the N-terminal 
and central parts of nsP1 mediate binding to the plasma membrane [115,118], 
and second, the interaction is fortified by the palmitoylation of Cys residues 
located in the C-terminal part of the protein [118]. The first binding step is 
mediated by a stretch of staggered positively charged and hydrophobic aa resi-
dues with the sequence G245STLYTESRKLLRSWHLPS263V [115], which is 
organized into an amphipathic helix. The corresponding sequence is conserved 
among alphaviruses, and the binding that is mediated by this element is essen-
tial for viral replication [118,119]. Furthermore, similar sequences can be found 
in proteins homologous to nsP1 in other viruses belonging to the superfamily of 
alphavirus-like viruses [120]. 
The amphipathic membrane binding peptide in the middle portion of nsP1 is 
prone to forming interactions with negatively charged parts of the membrane 
phospholipids, such as phosphatidylserine [118]. A synthetic peptide with this 
sequence competes with nsP1 for binding to negatively charged phospholipids. 
The sequence also acts as a weak membrane localization signal because two or 
more copies of this peptide can direct enhanced green fluorescent protein 
(EGFP) to nonspecific membranous fractions in the cell [119]. Mutations in the 
conserved hydrophobic residues in the amphipathic helix not only affect the 
binding of nsP1 to liposomes and membranes but also strongly diminish the 
enzymatic activity of nsP1, especially the methyltransferase activity [115,120]. 
The introduction of point mutations into the amphipathic helix region often 
leads to the selection of secondary compensatory mutations located near or 
distant from the helix [119]. This finding supports the idea of a central role for 
the helix in mediating contacts between different portions of the replicase. 
However, as with many functions of alphavirus-encoded proteins, the require-
ment for membrane attachment of nsP1 appears not to be absolute. Thus, nsP1 
from SINV is enzymatically active even in the absence of membranes [121]. 
The second binding step is mediated by the post-translational palmitoylation 
of cysteine residues 418-420 in the CC419C sequence in nsP1 of SFV, and this 
modification strongly binds the protein to membranes [118,122]. The pal-
mitoylated form of nsP1 causes the decomposition of actin stress fibers [116]. 
However, the palmitoylation step is not absolutely required for SFV. Mutant 
nsP1, in which the CC419C sequence is replaced with non-palmitoylated Ala 
residues (AA419A sequence), exhibits 40% of the guanylyltransferase and me-
thyltransferase activities of wt nsP1 [118]. NsP1 that is not palmitoylated does 
not induce the formation of filopodia-like structures [118,122] and the mutant 
nsP1 tends to localize on cytoplasmic membranes. A virus carrying such a mu-
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tation is also viable, although this virus has a lower growth rate than the wt 
virus [122] and is less pathogenic. This virus does not cause plaque formation in 
certain cell lines, and the virus cannot be found in the brains of infected mice 
even though it causes blood viremia [122]. However, the rescued virus does not 
represent the original mutant but is rather a mixture of viruses with different 
pseudoreversions (unpublished data from our research group). These second-
site mutations arise rapidly for the palmitoylation-deficient SFV mutants, which 
have extremely low original infectivity [123]. The defect, which is responsible 
for the low infectivity and the selection of pseudoreversions, was due to the 
inability of the mutant protein to interact with nsP4. Thus, second-site compen-
satory mutations, which restore the nsP1:nsP4 interactions and, in some cases, 
the induction of filopodia-like structures, were selected [123]. This result agrees 
with several previously published co-immunoprecipitation analyses that demon-
strated that nsP1 contacts nsP4 directly [33,124], and nsP3 probably indirectly 
with the aid of cellular proteins [102,117]. Thus far, neither direct nor indirect 
contacts between mature nsP1 and nsP2 have been described. 
NsP2 in SFV consists of 798 aa residues and has a molecular mass of 86 
kDa [103,125]. In SFV-infected cells, approximately half of the synthesized 
nsP2 is localized in the nucleus, mainly in the nucleolus [102,126]. This 
localization pattern is presumably due to the presence of a PRR649R sequence, 
which is thought to function as a nuclear localization signal (NLS). However, 
the activity of this signal also depends on the surrounding protein context. For 
nucleolar targeting of SFV nsP2, an additional sequence element located be-
tween aa residues 470-489 is necessary [127]. Mutations in the NLS that result 
in the cytoplasmic localization of nsP2 are not lethal to the virus. Such recom-
binant viruses replicate well in cell culture but are less pathogenic in mice. This 
reduced pathogenicity is likely due to the inability of such viruses to interfere 
sufficiently with host cell antiviral responses, most importantly with the expres-
sion and secretion of type I IFN [128]. In addition to the specific suppression of 
host antiviral gene expression, nsP2 in Old World alphaviruses also participates 
in shutting down host cell transcription in general. Therefore, nsP2 is consid-
ered to be the main determinant for the cytotoxicity caused by SFV and SINV 
[20,129]. NsP2 also causes the degradation of the catalytic subunit of mamma-
lian (but not insect) RNA polymerase II [130]. 
The N-terminal half of nsP2 is an Mg2+-dependent RNA triphosphatase 
[131] and nucleotide triphosphatase (NTPase) [132]. SFV nsP2 contains the 
universal NTP binding motifs GVPGSGK192S and YVDEAF255A [133,134]. 
The affinity of nsP2 to the RNA substrate is approximately 30-fold higher than 
to NTPs [131]. The full-length SFV nsP2 has also RNA helicase activity [135]. 
In contrast to the NTPase and RNA triphosphatase activities, both the N-termi-
nal and C-terminal domains of nsP2 are required for the RNA helicase activity. 
Recent unpublished studies from our laboratory have shown that this indeed is 
the case. 
The crystal structure of the C-terminal portion of nsP2 has been resolved for 
several alphaviruses, including VEEV [136]. The C-terminal region of nsP2 
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contains a papain-like protease domain and a methyltransferase-like domain. 
The latter is enzymatically inactive because some essential structural elements 
are missing. However, nsP2 is a well-known atypical Cys-protease that has 
His548 and Cys478 (numbering according to SFV nsP2) in its catalytic center 
[136,137]. The substitution of Cys478 with Ala results in an protease-inactive 
nsP2 [16], and ns-polyproteins containing this mutation have been used as sub-
strates for nsP2 in several studies. Three other conserved amino acids in nsP2 
coding region are Trp549, Asn600 and Asn605; mutations in these residues either 
inactivate the enzyme completely or significantly impair its activity. In addition, 
the Gly residue at the penultimate position upstream of the scissile bond of the 
cleavage site is absolutely required for nsP2 protease activity; replacement of 
this Gly residue with a Glu residue renders the corresponding substrate non-
cleavable [138]. This Gly residue is conserved in all cleavage sites in SFV ns-
polyproteins (See III, Fig. 2a for clarification). 
The protease activity of nsP2 is resistant to some common inhibitors of Cys 
proteases but is sensitive to others. Its activity is dependent on some divalent 
cations: Cu2+ and Zn2+ inhibit protease activity completely; Co2+ and Ni2+ par-
tially inhibit its activity; and Ca2+, Mg2+, and Mn2+ do not influence protease 
activity. Thus far, the only known substrates for nsP2 are the ns-polyproteins 
from the virus. A recombinant protein with the protease domain can cleave the 
ns-polyprotein between nsP3 and nsP4 (the 3/4 site; hereafter similar abbrevia-
tions are used for other cleavage sites) and cleaves the 1/2 site less efficiently 
[139,140]. These cleavages are independent of the free N-terminus of nsP2 and 
can also be performed by the nsP2-containing polyprotein [139,140]. In con-
trast, the cleavage of the 2/3 site can be performed only by nsP2 with a free and 
native N-terminus [141]. These results and previous mutational analyses sug-
gest that interdomain interactions occur between the C-terminal protease and 
the N-terminal domain of nsP2 [139,142]. 
NsP3 in SFV consists of 482 aa residues and has a molecular mass of 61 
kDa [103]. The protein is essential for synthesizing RNA with negative 
[104,114] and positive polarity [114]. NsP3 is the only ns-protein that is phos-
phorylated in infected mammalian cells [143]. When expressed alone, nsP3 is 
dispersed in punctate granules throughout the cytoplasm of the cell. In immuno-
fluorescence microscopy, these granulated structures appear similar to the virus 
replication sites (CPVs), but the structures lack the fine ultrastructural charac-
teristics of CPVs and do not co-localize with lysosomal membranes [117,144]. 
Thus, nsP3 is not the only factor required for the formation of CPVs that are 
required for RNA replication. However, the nsP3 part of the P123 polyprotein 
directs the future viral components of the replication complex to the endosomal 
membranes in mammalian cells [117]. 
The N-terminal one third of nsP3 is a macro-domain that is conserved 
among alphaviruses, coronaviruses and rubella virus [145]. The three-dimen-
sional structure of this domain has been resolved for many alphaviruses. The 
macro-domain of nsP3 in CHIKV and VEEV has been shown to bind ADP 
ribose [146]. However, this property is not conserved because the same domain 
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from SFV and SINV does not bind ADP ribose. Instead, this domain can bind 
poly-ADP ribose and poly(ADP) [147], indicating its likely role in RNA bind-
ing. The N-terminal macrodomain of nsP3 functions, albeit very poorly in SFV, 
as a phosphatase for ADP-ribose 1-phosphate [146,148]. The significance of 
this activity for the virus is not known. 
The middle portion of nsP3 is conserved only among alphaviruses. The 
three-dimensional structure of this region is only known for SINV [149]; how-
ever, the sequence similarity between these domains of different alphaviruses 
suggests that the fold is conserved for all of them. The most prominent function 
of this domain is binding Zn2+, and this function is crucial for virus infectivity 
[149]. 
The C-terminal portion of nsP3 is highly variable both in sequence and in 
length. Nevertheless, for all known alphaviruses, this region contains Ser and 
Thr residues that can be phosphorylated [143]. NsP3 has no kinase activities; 
therefore, this region must be phosphorylated by cellular kinases. Viruses with 
mutated nsP3 that cannot be phosphorylated are viable but less pathogenic in 
mice [150]. NsP3 is degraded quickly in the cell when not stabilized by other 
components of the replicase complex; this degradation occurs due to the pres-
ence of a specific degradation signal in the C-terminus. If the degradation signal 
with residues immediately upstream are removed, an individually expressed 
nsP3 becomes stable and localizes to filamentous stretches inside the cytoplasm 
[144]. In contrast to the first domains of nsP3, the C-terminal domain lacks a 
definite three-dimensional structure. Numerous studies have indicated the role 
of this domain in interactions with several host proteins, including G3PB (Ras-
GAP Src-homology 3 domain binding proteins) [151] and amphiphysins [152]. 
NsP4 is the catalytic subunit of the alphavirus replicase [153]. In SFV, nsP4 
consists of 614 aa residues and has a molecular mass of 68 kDa [103]. On its 
own, nsP4 is the most unstable ns-protein of alphaviruses [103]; nsP4 is rapidly 
degraded by the N-end rule [154]. The reason for this degradation is the N-
terminal Tyr residue in nsP4. This residue is essential for the viability of the 
virus; a non-aromatic residue at this position severely impairs replication [155]. 
When expressed alone in a cell, nsP4 stabilized by the presence of a non-na-
tive N-terminal Met residue is distributed in the cytoplasm in a punctuate man-
ner [102]. Whether this localization occurs for native nsP4 is unclear because 
the protein is too unstable to be detected (unpublished data from our labora-
tory). In some strains of SFV and most other alphaviruses (including SINV), 
nsP4 is produced by the read-through of an opal termination codon located near 
the 3’ end of the nsP3 encoding sequence [156]. Even if other termination co-
dons are inserted in place of opal, nsP4 is produced [157]. This result is due to 
the specific RNA sequence located near the read-through codon [158]. This 
mechanism, together with the rapid degradation of individual nsP4, ensures that 
the amounts of nsP4 in infected cells are much lower than any other ns-protein. 
In contrast, most SFV strains have an arginine codon at the position of the ter-
mination codon, and the amount of expressed nsP4 is equal to other ns-proteins 
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[133]; however, nsP4 that is not included in formed replicase complexes is rap-
idly degraded.  
In vitro, nsP4 possesses de novo RNA synthesis activity [153] and terminal 
nucleotide transferase activity [159] with a strong preference for adding adeno-
sine nucleotides [160]. Together with the finding that the site of negative-strand 
RNA synthesis initiation is located at last C-nucleotide in CSE4 [161], this 
result indicates that alphaviruses do not use a poly(U) template for synthesizing 
the poly(A) tails of positive-strand RNAs; instead, such tails are synthesized by 
the terminal transferase activity of nsP4.  
NsP4 has a relatively long N-terminal domain that is conserved among al-
phaviruses but lacks homology with any other known protein sequence [153]. 
This sequence is likely involved in interactions with other ns-proteins, including 
nsP1, and host factors [33,124]. To synthesize RNA of negative polarity, nsP4 
with this N-terminal region and the presence of non-processed P123 are re-
quired. The synthesis of positive-strands depends on other factors; nsP4 alone is 
capable of synthesizing genomic RNAs, while nsP2 is also required for sg 
RNAs [153]. 
 
 
2.4 The replicase complex: membrane binding,  
replication and transcription.  
The expression of four ns-proteins as individual proteins in the same cell cannot 
lead to successful replication complex formation. However, when the ns-pro-
teins are expressed in the form of P1234 (or P123 plus nsP4 with a native N-
terminus), the formation of replicase complexes and RNA replication is ob-
served if a suitable template is provided [162,163]. This requirement implies 
that the formation of replicase complexes depends on viral RNAs, the interac-
tions between ns-polyproteins and their cleavage process and cellular compo-
nents (such as membranes). 
 
 
2.4.1 Formation of replicase complexes (spherule)  
and replication organelles (CPV). 
The replication of alphaviruses in mammalian cells occurs in association with 
cellular endosomal membranes, where small membranous invaginations, called 
spherules (approximately 50 nm in diameter), are formed [71,102]; [164]. 
Spherules are located at the outer membrane of large vesicles (up to 2 μm in 
diameter); these virus replication organelles are also called cytopathic vacuoles 
type I (CPV). CPVs contain multiple spherules, each of which contains all rep-
licase proteins and viral RNA [114]. Thus, a spherule represents the replication 
complex of alphaviruses. The inner volume of each spherule is connected to the 
cytoplasm with an electron-dense structure resembling a neck [102,117,165]. 
The neck is thought to be the route that newly synthesized viral RNAs use to 
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enter the cytoplasm and the route through which NTP substrates are transported 
to the spherule. 
RNA synthesis coincides with spherule formation at the plasma membrane, 
and no spherule formation can be observed in the absence of RNA replication 
[162,163]. Though the spherules are initially formed at plasma membranes, the 
spherule-containing membranes are subsequently internalized with the aid of 
phosphatidylinositol 3-kinase and the actin network to form neutral vesicles that 
undergo short, fast and multidirectional movements. Larger vesicles that are 
formed by the fusion of vesicles with more acidic compartments use microtu-
bules to move long distances. Ultimately, CPVs are formed, which tend to lo-
calize around the nucleus in SFV-infected cells [166]. For these processes, the 
coordinated action of several ns-polyproteins and nsPs are needed. NsP1 
anchors the replication complex to membranes [115,118,119], while nsP3 is 
important for transport to the lysosomal compartment [117]. The spherule-con-
taining structures can also move and merge within a cell and bud and invaginate 
from the plasma membrane [102]. 
 
 
2.4.2 Replication and transcription 
Viral genomic RNA is the matrix for the translation of ns-polyproteins 
[81,103,125], which are gradually cleaved by nsP2 [16]. First, the early repli-
case synthesizes the negative-strand of RNA. This strand is used as a template 
by the late replicase, which synthesizes new genomic and sg RNAs [14,18,167]. 
The conversion from the early to late replication complex is mediated by the 
sequential cleavage of ns-polyproteins and their acquired conformations. The 
combination of P123 and nsP4 preferably synthesizes negative-strand RNA 
(early replicase), while the late replicase complex that consists of fully cleaved 
ns-proteins synthesizes positive-strand RNA [14,103]. The artificially stabilized 
cleavage intermediate that consists of nsP1, nsP4 and P23 is capable of synthe-
sizing RNA strands with both positive and negative polarity [14]. 
The negative-strand RNA lacks a poly(U) tract in its 5’ end, although the 
corresponding positive-strands contain a 3’ poly(A) sequence [70,161]. Simi-
larly, negative-strand RNA lacks the 5’ cap structure but has one extra, non-
templated G residue at the 3’ end [168]. Analysis of RNA synthesis intermedi-
ates has revealed that the negative-strand does not exist as a free ssRNA mole-
cule; instead, the negative-strand forms a duplex with the positive-strand of 
RNA [169,170]. Several forms of dsRNAs, designated replication intermedi-
ates, can be purified from alphavirus-infected cells. The synthesis of negative-
strand RNA generally stops approximately 4 h post-infection [19]; however, 
continuous negative-strand RNA synthesis is observed in certain mutant viruses 
carrying mutations in the nsP2 coding region [170,171]. As with all alphavirus 
RNAs, the synthesis of negative-strand RNA also depends on nsP4; mutations 
in the nsP4 coding region may render a virus temperature-sensitive, which 
means that the virus has a reduced negative-strand RNA synthesis rate and im-
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paired virion release at the restrictive temperature [172]. Defects in alphavirus 
negative-strand RNA synthesis can also arise from mutations in the nsP3 coding 
region [107,173] or nsP1 portion [106]; the latter is likely due to impaired 
interactions between nsP1 and nsP4 [33,124]. Thus, the type of RNA synthe-
sized in an alphavirus-infected cell depends on the number of scissile bonds that 
have been cleaved in a polyprotein and on the presence of mutations in several 
replicase protein coding sequences. Furthermore, mutations that modify the 
RNA synthesis ability of an early or late replicase have been described. First, 
SINV [174] and SFV (III) can synthesize positive-strand RNAs even if P123 
cannot be processed; only one (SINV) or two (SFV) point mutations in the ns-
polyprotein coding regions are required to re-gain this activity. Second, several 
temperature-sensitive mutants of SFV and SINV can re-activate negative-strand 
RNA synthesis at the restrictive temperature [175,176]. These findings suggest 
that ns-polyprotein processing does not have a decisive role in determining 
strand synthesis specificity; other factors may have equally or more important 
roles. 
NsP2 is the enzyme that performs the gradual cleavage of the ns-polyprotein. 
To achieve the formation of a functional replicase, the processing of the ns-
polyprotein must be highly regulated. First, the rapid cleavage of the 3/4 site 
occurs, most likely in cis (Fig. 3). This step is followed by a much slower 
cleavage of the 1/2 site, which only occurs in cis (except in the presence of a 
large excess of free nsP2 in a test-tube reaction). The final step of the ns-poly-
protein processing is the extremely fast cleavage of the 2/3 site in trans. The 
latter occurs only when the N-terminal part of nsP2 has been released [16,138]. 
The main determinants for the 3/4 site cleavage are 4 aa residues preceding (P-
side) and one aa residue following (P’-side) the scissile bond [15]. The 2/3 site 
cleavage is driven by the correct macromolecular assembly rather than by the 
sequence of the cleavage site; both the macro-domain of nsP3 and the N-termi-
nal portion of nsP2 are responsible for placing the scissile bond correctly in the 
cleavage pocket [141]. As the amount of free nsP2 increases late in the infec-
tion, the cleavage of P1234 at the 2/3 site dominates over other polyprotein 
cleavages [177], resulting in the cessation of early replicase complex formation. 
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Figure 3. Schematic representation of cleavages of ns- and structural polyproteins. The ns-
polyprotein P1234 is cleaved differently during the early and late phases of infection. During the 
early phase, processing begins with the release of nsP4 from P1234; this cleavage is performed in 
cis and results in the P123 + nsP4 complex that can synthesize negative-strand RNA. The sub-
sequent in cis cleavage between nsP1 and P23 is followed by a rapid trans cleavage of the site 
between nsP2 and nsP3. These cleavages convert early replicase to the late replicase, which loses 
its ability to synthesize RNA with negative polarity but can synthesize positive-strand genomes 
and sg RNAs. During the later phase of infection, free nsP2 is abundantly present in the cyto-
plasm of the infected cell. This protein can cleave P1234 in trans at the cleavage site between 
nsP2 and nsP3, resulting in the presence of P12 and P34. These polyproteins can neither form 
replicase complexes nor synthesize RNA of any polarity; therefore, the formation of new repli-
case complexes is halted. P12 and P34 are processed into mature ns-proteins, which have specific 
functions not directly related to viral RNA synthesis. 
The C protein is released from the structural polyprotein by autoproteolysis, which occurs im-
mediately after this part of the polyprotein is synthesized. P62, 6K, trans-frame protein (not 
shown in the figure) and E1 are released by cleavages performed by cellular proteases; these clea-
vages occur during the translocation of the corresponding part of the polyprotein through the 
endoplasmic reticulum. p62 is cleaved into E3 and E2 during the transport from the endoplasmic 
reticulum to the plasma membrane. 
 
 
Alphavirus replication complexes are formed only if nsP1, nsP2 and nsP3 are 
expressed in the form of the polyprotein P123(4) [178]. The forming replicase 
complex can engage any RNA with the correct CSEs. During native infection, 
the involved RNA is most often the RNA genome that was used for the 
translation of the ns-polyprotein (template present in cis); however, templates 
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presented in trans, such as DI RNA or helper RNA, can be used to trigger 
spherule formation and start replication. The size of spherules and the length of 
RNA engaged in replication are directly correlated [179]. 
Alphaviral sg RNA is transcribed using the negative-strand RNA as a tem-
plate [86,156], and it corresponds to the last one third of the genome [180]. The 
synthesis of sg RNA depends on nsP2 [181], which directs the polymerase to-
ward sg RNA synthesis when bound to the negative-strand RNA [169]. In infec-
tions with some temperature-sensitive mutants, the mutant nsP2 detaches from 
the template at the restrictive condition. This detachment results in the cessation 
of sg RNA synthesis, but the synthesis can be restarted when cells are returned 
to the permissive temperature [169]. Similarly, some mutations in the nsP2 
coding region render the virus temperature-sensitive due to a decrease in the 
amount of sg RNA synthesized under restrictive conditions [182]. 
For several alphaviruses, a 21-nt CSE2 has been identified as a major part of 
a minimal promoter for sg RNA synthesis; the promoter is generally 24 nt (from 
-19 to +5) long [75]. This sequence exhibits lower activity in directing sg RNA 
synthesis than the complete promoter, which is considerably longer [183]. This 
difference may be due to the presence of several enhancing sequences in the 
complete promoter. Such elements may contribute to the efficient transcription 
of the sg RNA in mammalian and mosquito cell lines [184]. The length of the 
minimal sg promoter is not identical among different alphaviruses. To achieve 
sg RNA synthesis, the SFV sg promoter needs to be longer, spanning from 26 nt 
upstream to 20 nt downstream of the starting site of sg RNA synthesis [185]. 
The differences in sg promoter length are thought to be a consequence of the G 
residue at the -1 position of the SFV sg promoter; in SINV and most other al-
phaviruses, this position is occupied by an U residue [186]. 
 
 
2.5 Structural proteins and their expression 
SFV structural proteins are translated as a single C-E3-E2-6K-E1 polyprotein 
from the sg RNA. The E3-E2 part of the polyprotein has the longest half-life 
and is also called p62 according to its molecular mass [81,86,125,187]. The 
translation of structural proteins is activated by a translation enhancer, which is 
an element encoded by the first 102 nt of the capsid protein-encoding sequence 
[78]. The enhancer is functional only in wt SFV-infected vertebrate cells [188]. 
After the cleavage of the C protein from the N-terminal part of the structural 
polyprotein, the N-terminus of p62 is released [83] and functions as a mem-
brane translocation signal. The binding to membranes is required for correct 
folding, processing and modification of the remaining structural proteins. Al-
phaviruses encode three glycoproteins: E3, E2 and E1 [189]. Several transloca-
tion signals are required for the correct folding of the glycoproteins into the 
membranes. First, the N-terminal part of p62 begins the translocation into the 
endoplasmic reticulum membranes, where p62 becomes glycosylated [83]. 
Second, the C-terminal segment of p62 is required to initiate 6K and E1 translo-
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cation [84]. Third, the hydrophobic peptide in the C-terminus of the 6K protein 
is required for stopping and anchoring 6K and E1 protein translocation [85]. 
The cleavage events between p62/6K and 6K/E1 are likely performed by a cel-
lular enzyme signal peptidase [84,86]. As indicated above, p62 is cleaved at the 
end of the viral structural protein maturation process. p62 forms complexes with 
E1, and the final cleavage occurs just before these complexes arrive at the 
plasma membrane [90]. The structure of the carbohydrate component of all the 
glycoproteins is strongly dependent on the host. SINV virions formed in mos-
quito cells have mannose sugars added to the glycoproteins, whereas several 
glycans are preferred for the same virions formed in vertebrate cells [190,191]. 
Capsid protein (C; 33 kDa) is the only structural protein with enzymatic ac-
tivity. Capsid protein is an autoprotease that removes itself from the structural 
polyprotein [82]. The protease domain found in the highly conserved C-termi-
nus of the capsid protein [192] shares homology with the conserved sequences 
of serine proteases [193]. The C-terminal part of the capsid protein also binds to 
the cytoplasmic region of E2 [44], while its N-terminal region, which is rich in 
positively charged aa residues, binds viral RNA [79]. In this manner, the capsid 
protein participates in the formation of a two-layered protection for the virus 
genome. 
E3 is an 11 kDa glycoprotein [189,194] that mediates the proper folding of 
p62 [83]. E3 remains peripherally associated with the major spike proteins 
[195] and modulates particle assembly and spike activation for viral entry [196]. 
p62:E1 complexes are stable at a low pH, which is important for viral protein 
transport through the acidic cellular compartments. However, if the cleavage of 
p62 is blocked, highly stable virions that are also insensitive to a low pH are 
formed and the effectiveness of the viral infection is impaired [92]. 
E2 is an approximately 51 kDa transmembrane glycoprotein [189] that is 
also palmitoylated. This modification is essential for the efficient budding of the 
virions [197]. E2 assists the correct localization of other glycoproteins into the 
membrane [83] and is responsible for binding mature virions to cellular recep-
tors during the early steps of infection. The binding is mediated by the tip of E2 
in its trimeric conformation [52]. E2 also contains the major epitopes to which 
neutralizing antibodies bind [51]. 
6K is a 60 aa residue-long hydrophobic transmembrane protein [84]. 6K can 
be translated in two forms: the shorter 6 kDa protein and the recently discovered 
longer trans-frame 8 kDa protein (synthesized via ribosomal frame shifting 
occurring with 10-18% effectiveness). The trans-frame protein is more abun-
dant in SFV virions [198], although to a lower extent than glycoproteins. Both 
proteins are acylated [199], and the trans-frame protein is more heavily pal-
mitoylated than the shorter form of the protein [198]. 
Although present in virions, the exact function of the protein is not known; 
deletion of 6K and/or its trans-frame part of the protein decreases virus release 
but does not interfere with spike protein complex formation or with transport to 
the cell membrane [187]. The signal sequence present in the C-terminus of the 
alphaviral 6K protein contributes to the correct localization of the E1 protein 
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[85] and enhances the budding process [200]. In addition, the protein can form 
ion channels [201], which is thought to be a contributing factor to the budding 
process. However, both the 6K and trans-frame proteins are essential for alpha-
virus pathogenesis in vivo [202]. 
E1 is an approximately 50 kDa transmembrane glycoprotein [189] that is 
palmitoylated [203]. Palmitoylation of E1 contributes to the stability of the 
budding virions [204]. E1 is responsible for the acid-induced fusion of lysoso-
mal and virion membranes during virus entry [60,62,205]. The E1 resident pep-
tide is also proposed to have a role in the formation of ion-permeable pores, 
which are important for the acidification of cytoplasmic vacuoles and, thus, the 
infection process [206]. 
 
 
2.6 Alphaviruses in mosquito cells 
Mosquitoes are the arthropod vectors for most alphaviruses. In general, the 
infection in mosquito cells and especially living mosquitoes is much less under-
stood than the infection in vertebrate cells and organisms. Several factors are 
common for the replication of alphaviruses in both mosquito and vertebrate 
cells. One of these factors is the requirement for cholesterol in the membranes 
of the infected cells. Mosquito cells depleted of cholesterol are resistant to SFV 
infection, a defect that has been attributed to the inhibition of membrane fusion 
events [207]. The dependence on cholesterol has also been demonstrated on 
virion exit stages [99]. Other factors that are similar between the infection pro-
cesses in different hosts include cytoplasmic replication and the order of the 
processes associated with RNA replication. 
As described previously in the above sections, a number of important differ-
ences can be found between infections in different host cells. For example, 
virion budding can occur on both the plasma membrane and cytoplasmic vesi-
cles in mosquito cells [101]. Virus survival in mosquito cells depends on the 
native sequences and functions of the viral ns-proteins and CSEs. In general, 
mutations in these regions affect virus fitness in the mosquito more severely 
than in vertebrate cells, although examples of the opposite are also known. 
Thus, certain changes in the viral 3’ UTR or nsP4 coding sequences affect viral 
RNA release in mosquito cells to a greater extent than in their vertebrate coun-
terparts [30,208]. However, the majority of known differences between infec-
tions in vertebrate and insect hosts are related to virus-host interactions. 
Much of the research on alphaviruses and their vectors has been conducted 
using cell lines derived from mosquito larvae. Furthermore, alphaviruses also 
infect fruit fly cells (Drosophila melanogaster) reasonably well, and this model 
organism can be used for in vivo infections as well. Depending on the cell line, 
significant morphological changes and cytopathic effects can appear during the 
infection, but eventually all insect cell lines exhibit a cured phenotype [101]. 
The typical infection can be described as follows. The initial acute phase of 
replication is characterized by the infection of all the cells in the cell culture (at 
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least if a high MOI is used) and a high level of viral progeny production. How-
ever, this phase is followed by a persistent phase, and only approximately 2% of 
cells remain infected at 48 hours post-infection. The persistent phase is associ-
ated with a sharp decrease in virion production [26]. The low levels of 
extracellular virus production are essential for maintaining persistent infection 
[209] because a constant re-infection of cured cells by the virus emerging from 
infected cells occurs during this phase. 
The molecular mechanisms for generating persistent infection in mosquitoes 
are not fully understood. Some evidence suggests that the persistent infection is 
regulated by the inhibition of negative-strand RNA synthesis, which itself re-
sults from changes in the ns-polyprotein processing pattern [167]. In cell clones 
with fewer virus-induced cytopathic effects, less RNA with negative polarity is 
synthesized [28]. However, recent studies have shown a leading role of the 
general immune signaling pathways, RNA interference (RNAi) [29] and PIWI-
interacting RNAs (piRNAs) [210] in controlling the alphavirus infection in 
mosquitoes. 
The activation of some innate immune signaling pathways in mosquito cells 
before infecting them with SFV reduces subsequent virus replication. However, 
the viral infection itself does not activate these pathways. Despite the inability 
to interfere with the already activated immune signaling pathways, the virus can 
reduce cellular gene expression in mosquito cells and, while doing so, likely 
suppress gene activation before an immune response can be established [211]. 
In vertebrates, dsRNA often triggers the induction of antiviral genes (for ex-
ample, type I interferons); dsRNA may also trigger the production of small 
interfering RNAs (siRNA) [212]. In vertebrate cells, the existence and role of 
siRNAs that are generated in response to alphavirus infection are unclear. In 
contrast, such siRNAs are used in the RNAi pathway in both mosquito cells and 
mosquitoes [213,214]. For alphaviruses, the dsRNA replication intermediate is 
used for generating siRNAs, confirming the historical finding that the emer-
gence of dsRNAs in an alphavirus infection can be detected in insect cells [32]. 
Furthermore, using massive parallel sequencing, it has been revealed that some 
sequences in the viral genome are more frequently present in siRNAs than oth-
ers. However, these so-called “hot-spot” siRNAs are less potent in inducing the 
silencing of virus replication than less abundant (“cold spot”) derived siRNAs 
[215]. Thus, the virus appears to allow the host defense systems to react against 
the sequences that counteract replication to a smaller extent, whereas sequences 
with a vast influence on replication are thereby protected. 
Gap junctions are present between individual cells in mosquito cell culture 
[216]. These junctions allow the spread of siRNAs from infected cells to unin-
fected neighboring cells. Such cell-to-cell spreading of the RNAi response sup-
presses SFV infection in mosquito cell cultures because the virus is unable to 
reduce this effect. However, if a viral suppressor of RNAi from another virus is 
expressed in these cells, SFV replication and particularly its spread in cell cul-
tures is enhanced [217]. Most likely, a similar effect also occurs in infected 
mosquitoes. 
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piRNAs regulate RNA silencing in the cell [218]. This mechanism was 
discovered in testis cells from the fruit fly and is thought to offer protection 
from transposable elements, thus ensuring genome stability [31,219]. In contrast 
to siRNA-induced gene silencing, the piRNA pathway is independent of Dicer-
mediated production from the dsRNA [212,218]. PIWI proteins are found in 
germ cells and are thought to reduce vertical virus transmission [210]. In 
mosquitoes, PIWI-like proteins have also been found in somatic cells [220]. 
Research on CHIKV suggests that the inducer of the piRNA pathway may be 
dsRNA, similar to the siRNA pathway [220]. However, other evidence suggests 
that ssRNA is required for the activation of the piRNA pathway in SFV-in-
fected cells [210]. Regardless of the mechanism of induction, SFV infection can 
trigger piRNA production in mosquito cells, and virus production is enhanced if 
the expression of piRNA pathway proteins is knocked down [210]. 
 
 
2.7 Alphaviral vectors 
Alphavirus vectors can be potentially used for vaccine construction, central 
nervous system disease therapy and anti-cancer therapy. These vectors are char-
acterized by their high biosafety, easy manipulation techniques and broad host 
range. Thus far, primarily animal models and alphavirus replicon vectors have 
been tested for such applications [221]. The use of replicon vectors is facilitated 
by the fact that foreign sequences of interest with lengths up to 9 kb can be 
inserted into a vector without affecting the formation of virus-replicon particles 
(VRPs) [222]. 
Alphavirus vectors can be used for the transient expression of foreign pro-
teins [221]. The highest expression levels can be achieved when the sequence of 
a translation enhancer is fused to the 5’ end of the coding sequence of the for-
eign protein [188]. These vector systems have been developed for several alpha-
viruses, including SFV [187], SINV [223,224] and others. Because an infection 
by replicon vectors of Old World alphaviruses is cytotoxic to the vertebrate 
host, a long-term and persistent replication can only be achieved when muta-
tions in the viral part of the vector render it non-cytopathic [223,225].  
Three different approaches are used for the transient use of alphavirus-based 
systems: VRPs, layered DNA-RNA vectors and replication-competent vectors 
[221]. The VRPs are designed to undergo a single round of replication because 
sequences coding for structural proteins are not included in the particle [8]. 
Layered vectors represent plasmids in which production of the replicon RNA is 
achieved by a cytomegalovirus early promoter placed upstream of a replicon 
cDNA. The primary problem with layered DNA-RNA vectors is their low trans-
fection efficiency when compared to infection with VRPs. However, the im-
mune responses obtained using this type of vector are much higher than those 
from DNA-based vaccines [226]. Replication-competent vectors express the 
transgene(s) in addition to viral genes, either via a duplicated sg promoter [185], 
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via an inserted internal ribosomal entry site (IRES) [227] or due to the insertion 
of the transgene sequence into the viral polyprotein coding regions [228,229]. 
In a replicon-VRP system, the structural polyprotein coding region is sub-
stituted with the sequence of interest. The packaging of these RNAs is achieved 
by their co-transfection with a helper RNA, which is capable of replication and 
encodes structural proteins [8]. However, only the replicon RNA is packaged 
into the particle because the signal required for encapsidation lies within the ns-
polyprotein coding region [79,80]. The probability of recombination between 
replicons and helper RNA represents a significant concern because this event 
may lead to the formation of an infectious virus. To diminish the recombination 
risk, split-helper systems have been developed. In this case, the regions encod-
ing structural proteins are provided from two different helpers [230]. In addi-
tion, mutations that attenuate the virus should the recombination event take 
place can also be inserted into the vector backbone [231]. Alternatively, the 
replication of the recombinant virus, resulting from a recombination event, can 
be blocked by the introduction of target sequences of cellular miRNAs [232]. 
For replication-competent alphavirus vectors, several additional issues need 
to be considered. The duplicated sg promoter and sequences expressed using 
this element are frequently removed from the vector genome because these 
sequences provide no selective advantage for the virus and instead slow down 
virus multiplication [185]. Other approaches that can solve or release the 
instability issue have been proposed. One possibility is inserting an IRES ele-
ment instead of an additional copy of the sg promoter. Unfortunately, this solu-
tion does not work equally well for all alphaviruses [185], and other adaptive 
mutations that ensure efficient replication emerge (Volkova et al., 2008). Thus, 
the outcome of IRES induction cannot be predicted easily. Inserting foreign 
sequences into viral polyprotein coding regions also results in more stable con-
structs. However, this technique is also the most labor-consuming approach 
because viral proteins that are vital to the virus are affected by transgene inser-
tion. To find the suitable insertion sites and develop insertion strategies, random 
mutant libraries have been screened [233]. Alternatively, an insertion strategy 
may be based on the data obtained for the processing of ns [228] or structural 
polyproteins [229]. 
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3 RESULTS AND DISCUSSION  
This PhD thesis summarizes research aiming to analyze the functions of the 
SFV replicase protein nsP1 during infection in vertebrate and insect cells. The 
importance of the release of nsP1 from the ns-polyprotein and the requirements 
for the processing of the 1/2 cleavage site are also analyzed. 
 
The aims of this study were as follows: 
1. to assess the influence of the defect in nsP1 palmitoylation on SFV infec-
tion in mammalian cells; 
2. to compare the effects observed for palmitoylation-deficient mutants in 
mammalian cells to those revealed in insect cells; 
3. to reveal the requirements for the release of nsP1 from the polyprotein 
precursor; and  
4. to analyze the importance of nsP1 release on virus replication and the im-
pact of this event on the antiviral innate immune response. 
 
 
3.1 NSP1 palmitoylation is dispensable  
for SFV replication (I) 
3.1.1 Design of palmitoylation-deficient SFVs 
It has previously been reported that nsP1 palmitoylation is not essential for SFV 
viability [122]. In contrast to these results, SFV replicon vectors harboring 
corresponding mutations in the nsP1 coding region were characterized by ex-
tremely low VRP production, indicating the presence of a serious replication 
defect. These data were in conflict with the previous report, and therefore, the 
effects of nsP1 palmitoylation on SFV viability were analyzed in a detailed 
manner. Three different mutants were constructed on the basis of an infectious 
pSP6-SFV4 clone [187] (I, Fig. 1). In SFV4mut3A, the three Cys residues in 
positions 418-420 in nsP1 were substituted with Ala residues; the corresponding 
residues were deleted in SFV43; and a large deletion including these Cys resi-
dues and four aa residues preceding the normally palmitoylated cysteine resi-
dues was generated in SFV4. The same mutations were also inserted into a 
SFV1 replicon [8], which also contained the EGFP coding sequences under the 
control of a sg promoter, and into an expression plasmid encoding individual 
nsP1. 
Transfection of BHK-21 cells with obtained replicons confirmed that less 
than 1% of cells transfected with transcripts of SFV1mut3A/d1EGFP or 
SFV13/d1EGFP expressed EGFP; in contrast, more than 90% of cells trans-
fected with the wt replicon transcripts were EGFP-positive. Thus, these muta-
tions in the palmitoylation site caused serious replication defect(s). Interest-
ingly, however, the results for SFV1d1EGFP were different; this mutation 
had only a moderate effect on replication as 40% of the cells transfected with 
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the corresponding transcripts expressed EGFP (I, Fig. 1, table). Therefore, it 
was hypothesized that the palmitoylation of nsP1 per se was not required for 
SFV infectivity and that the replication of SFV1mut3A/d1EGFP or SFV13/ 
d1EGFP was hampered due to some other defects caused by these (but not by 
Δ7) mutations. 
 
 
3.1.2 Characterization of palmitoylation-deficient SFVs 
An infectious center assay and growth curve experiments were used to assess 
the effect of diminished replication on virus viability and growth. Compared to 
wt SFV4, the infectivity of the SFV4mut3A and SFV43 genomes was dimin-
ished more than 20,000-fold (I, Fig. 1, table). The drastic decrease in infectivity 
resulted in a delayed release of progeny virions and, as a result, the yield of 
mutant viruses was considerably lower than that of SFV4 (I, Fig. 2a). Similarly, 
the infectivity of SFV47 was diminished, but to a much lesser extent, ap-
proximately 40-fold, and the decrease in virus release was less pronounced (I, 
Fig. 1 table, Fig. 2a). Upon transient expression, none of the mutant nsP1s were 
palmitoylated (Fig. 4b). Taken together, these results confirm that only a mod-
erate effect on replication can be directly attributed to the lack of nsP1 pal-
mitoylation. Hence, the serious defect in infectivity of SFV4mut3A and 
SFV43 must have another cause. The guanylyltransferase activities of the 
mutant nsP1s did not differ considerably from wt nsP1 (I, Fig. 4a), indicating 
that the synthesis of cap structures was not affected by the mutations. Therefore, 
the observed defect in infectivity of SFV4mut3A and SFV43 cannot be at-
tributed to the known enzymatic functions of nsP1 and lies elsewhere. 
The analysis of the subcellular localization of transiently expressed mutant 
nsP1 proteins in HeLa cells revealed that the wt nsP1 was localized mainly to 
the plasma membrane and caused an extensive induction of filopodia-like ex-
tensions, in agreement with previous reports. In contrast, nsP1-3, nsP1-7 and 
nsP1-mut3A did not induce the formation of filopodia-like extensions. Further-
more, the intracellular localization of nsP1-3 and nsP1-mut3A was clearly 
altered, as these proteins were not located solely on the plasma membranes but 
were also found in the cytoplasm of the transfected cells (I, Fig. 5a-d). 
Next, it was investigated whether the progeny viruses obtained from the cells 
transfected with mutant genomes were also impaired in their ability to grow in 
BHK-21 cells. It turned out that the differences between the mutant and wt 
viruses had disappeared (I, Fig. 2b). This data clearly indicates that during 
propagation in transfected cells, the fitness of the mutant viruses was largely 
restored. The most obvious reason for this result could be the reversion of mu-
tated sequences. However, sequencing of mutant virus stocks revealed that a 
reversion did not occur. Therefore, the increase in fitness must be attributed to 
some other changes, most likely to the creation of second-site compensatory 
mutations. 
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3.1.3 Identification and functional significance of  
compensatory mutations 
In general, RNA viruses tend to have multiple ways to compensate for any 
specific defect. Occasionally, one of these changes is more favorable than other 
changes. Therefore, one change quickly becomes dominant and can be revealed 
by sequencing viral stocks. In other cases, none of the multiple changes is fre-
quent enough to be detected using this approach, and massive parallel sequenc-
ing is required. However, at the time of this study (2005), such methods were 
not available. Therefore, to circumvent the problem of the possible mixed na-
ture of the original stocks, plaque purification was used. Four isolates from each 
mutant stock were obtained and analyzed for the presence of possible second-
site mutations in the ns-region. 
This analysis revealed three independent single aa changes (P181Q, L234F 
and Q357L; hereafter referred to as mut3A-1, 3A-2 and 3A-3, respectively) for 
the isolates purified from the primary stocks of SFV4mut3A and two double 
mutations (M124V+A197D and G224+T352S; hereafter referred to as 3-1 
and 3-2, respectively) for the isolates purified from the primary stocks of 
SFV43. All these mutations were located in the nsP1 coding region (I, Table 
1). In addition, two single aa changes in the nsP4 coding region, E127V and 
L583I, were revealed for the isolates purified from the primary stocks of 
SFV43 (unpublished results). All the analyzed viruses contained at least some 
of these mutations, strongly suggesting that these changes may be responsible 
for the increased fitness of the mutant viruses. In contrast, no second-site muta-
tions were discovered in the isolates of SFV47. Therefore, the sufficiently 
high infectivity of SFV47 likely prevented the fixation of a certain pseudo-
reversion because the growth advantage of such genotypes over SFV47 was 
not significant.  
The identified mutations were subsequently introduced into SFV4mut3A and 
SFV43, and the infectivities of the obtained constructs were assayed. The 
introduction of the compensatory changes found in nsP1 restored the infectivity 
of the mutant genomes to the levels similar to wt SFV4 (I, Table 1). In addition, 
no delays in virus release were observed, and only a minor diminution in the 
amounts of the released virions could be detected (I, Fig. 3). Thus, the intro-
duced compensatory changes indeed restored the fitness of the viral genomes 
encoding the palmitoylation-deficient nsP1. Furthermore, when the L234F mu-
tation, which was found in the SFV4mut3A background, was introduced into 
the SFV43 and SFV47 clones, the mutation restored the infectivity of 
SFV43 but did not increase the infectivity of SFV47 (I, Table 2). This find-
ing suggests that the 3 and mut3A mutations have a similar effect on nsP1, 
whereas the 7 mutation causes a different defect. 
In contrast to the compensatory mutations found in nsP1, the second-site 
mutations found in the nsP4 coding region failed to rescue the infectivity of 
SFV43 or SFV4mut3A (unpublished). This result indicates that the changes in 
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nsP4 may function together with some other mutations, for example, mutations 
that are located in the 5’ UTR or 3’ UTR, which were not sequenced. Never-
theless, the emergence of second-site mutations in the nsP4 coding region was 
highly coherent with previous reports that these two proteins interact with each 
other [102,117]. Therefore, compensatory changes in the nsP4 coding region 
that are capable of restoring the defect caused by mutations in the nsP1 coding 
region may exist. Massive parallel sequencing techniques could provide an 
insight into this issue. 
The emergence of mutations in the nsP4 coding region (though without a 
prominent effect) implied that the primary defect caused by the 3 and mut3A 
mutations, but not the 7 mutation, may be the disruption of interactions be-
tween nsP1 and nsP4. The revealed second-site mutations in the nsP1 coding 
region may serve to restore the nsP1:nsP4 interaction. To test this possibility, 
nsP4 was co-expressed with different nsP1 mutants, and the interaction between 
these two proteins was analyzed using immunoprecipitation. This assay re-
vealed that the 3 and mut3A mutations indeed resulted in the loss of an inter-
action with nsP4 and that this interaction was restored by all of the second-site 
mutations identified in the nsP1 coding region (I, Fig. 6). In contrast, none of 
these compensatory mutations restored the palmitoylation of nsP1 (I, Fig. 4b) or 
had a positive effect on the guanylyltransferase activities of the mutant proteins 
(in fact, the opposite was observed; I, Fig. 4a). The only additional effect, which 
was consistently observed, was a more extensive plasma membrane localization 
of palmitoylation-deficient nsP1s with second-site mutations (compared to 
nsP1-3 and nsP1-mut3A; I, Fig. 5e-i). Based on these results, it was hypothe-
sized that the plasma membrane localization of nsP1 is essential for its interac-
tion with nsP4. Notably, the ability to induce the formation of filopodium-like 
extensions was restored by the majority of, but not all, compensatory changes. 
Thus, the ability to induce filopodium-like extensions is not a pre-requisite for 
the viability of the virus. 
Taken together, it was found that although mutations in the nsP1 coding re-
gion that prevent its palmitoylation diminished the infectivity of the mutant 
genomes, these mutations did not block virus production. For SFV4mut3A and 
SFV43, virus production was associated with the accumulation of second-site 
compensatory changes. Primary mutations affected the plasma membrane lo-
calization of nsP1 and abolished its interaction with nsP4; compensatory 
changes restored these functions. Therefore, it can be concluded that pal-
mitoylation is not required for the efficient reproduction of SFV but has a sup-
porting role in the membrane association of nsP1, which is a pre-requisite for 
the formation of functional contacts with nsP4 and possibly other viral and host 
components that are important for replication. 
This analysis was largely completed eight years ago and, thus, had some 
limitations. First, the exact role of the plasma membrane in replicase complex 
formation was not known at this time but was described several years later 
[163]. Therefore, some implications of the observed effects were overlooked; 
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no attention was given to the possible role of the plasma membrane association 
of nsP1 in the formation of replicase complexes. Second, due to relatively high 
costs, the plaque-purified isolates were not completely sequenced. These 
sequences include the first 20 nt of the virus genome and sequences encoding 
structural proteins. Therefore, some mutations that also contribute to restoring 
the infectivity of the virus may lie inside these regions. Third, it is likely that the 
full spectrum of compensatory changes capable of rescuing the infectivity of the 
mutant genomes was not revealed. The application of massive parallel se-
quencing may provide new insights into this question.  
 
 
3.2 Mutations in nsP1 affect viral infection in  
mammalian and insect cells (I and II) 
3.2.1 Mutations resulting in non-palmitoylated nsP1 render SFV 
replicons temperature-sensitive  
The growth of SFV43 with potential compensatory mutations in the nsP4 
coding region was restricted at 37 °C but not at 28 °C. Based on this finding, 
other mutant viruses containing mutations in nsP1 (I, Table 1) were tested for 
temperature-sensitive phenotypes in vertebrate (mammalian BHK-21) and in-
vertebrate (mosquito C6/36) cells. 
First, to allow easy quantification of SFV replication, the coding sequence of 
Renilla luciferase (Rluc) was cloned into mutant replicon vectors (the original 
3 and mut3A and their combinations with compensatory changes in the nsP1 
coding region). The marker expression of these replicons has been shown pre-
viously to be proportional to the level of replication and transcription of the 
replicon RNA [234]. For this experiment, the benefit of replicon vectors over 
the full virus genome was minimization of the impact of novel adaptive muta-
tions because the replicons harboring such changes cannot spread in cell cul-
ture. 
It was found that in BHK-21 cells transfected with SFV1-enhRluc-3 and 
SFV1-enhRlucmut3A transcripts, Rluc expression at the permissive tempera-
ture (28 °C) was reduced approximately 1000-fold when compared to the ex-
pression level achieved using wt SFV1-enhRluc RNA transcripts (II, Fig. 1). At 
the restrictive temperature (39 °C), Rluc expression in the SFV1-enhRluc-3 
transfected cells was further diminished and was over 10,000-fold lower than 
for the wt-vector transfected cells at the same conditions. This result indicates 
that the defect caused by the 3 mutation depends on the temperature. No sim-
ilar effect was observed for SFV1-enhRlucmut3A, which expressed approxi-
mately 1000-fold less Rluc compared with wt SFV1-enhRluc at both tempera-
tures. As expected, the previously identified compensatory mutations increased 
the levels of Rluc expression by SFV1-enhRlucmut3A and SFV1-enhRluc-3 
up to 100-fold; this increase was observed at both temperatures. Compensatory 
mutations had a greater enhancing effect on Rluc expression by SFV1-
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enhRlucmut3A than by SFV1-enhRluc-3 (II, Fig. 1). A difference was not 
observed when full-length viral genomes were used (I), indicating that the 
method using combined replicon vectors with marker genes exhibits higher 
sensitivity than experiments based on the analysis of replication-competent 
viruses. 
Transfection of C6/36 cells with in vitro synthesized RNA transcripts was 
found to be quite inefficient (several reagents and transfection procedures were 
tested). Therefore, the observed Rluc activities in mosquito cells were always 
significantly lower than those obtained in vertebrate cells. Nevertheless, clear 
differences between the constructs were also observed in C6/36 cells, and the 
overall outcome of the experiment was relatively similar in both cell lines. First, 
the decrease in Rluc expression levels achieved using replicons harboring Δ3 
and mut3A mutations was up to 1000-fold at the permissive temperature (28 
°C). Second, no further decrease was observed in the SFV1-enhRlucmut3A 
transfected cells at the restrictive temperature (34.5 oC), whereas at the restric-
tive temperature, SFV1-enhRluc-3-transfected cells expressed up to 10,000-
fold less Rluc than cells transfected with wt SFV1-enhRluc. Thus, the 3 con-
struct was found to have a temperature-sensitive phenotype in mosquito cells as 
well. Compensatory mutations that were originally selected in mammalian cells 
were found to affect Rluc production ambiguously. Combined with the original 
mut3A mutation, the compensatory changes increased marker protein expres-
sion up to 100-fold; the effect was nearly identical to that observed in BHK-21 
cells. In contrast, combining compensatory changes with the 3 mutation fur-
ther diminished Rluc expression levels at the permissive temperature (approxi-
mately 10-fold), while Rluc expression was essentially abolished at the restric-
tive temperature (II, Fig. 1). Thus, in the context of the SFV1-enhRluc-3 repli-
con, the selected compensatory mutations displayed cell type-specific effects; 
an increase in replication levels was observed in mammalian cells, while the 
opposite effect was observed in insect cells. Thus, this analysis confirmed that 
the defects caused by the mut3A and Δ3 changes are similar but not identical. 
 
 
3.2.2 Cytotoxic effects of mutant replicons in vertebrate cells 
Previous reports have demonstrated that many mutations in the ns-protein cod-
ing region inhibit the ability of the virus to shut down host protein synthesis. 
When introduced into a replicon, these mutations reduce the virus’ cytotoxicity 
and allow longer expression of the desired recombinant protein [129,225]. 
Therefore, one of the original reasons for creating SFV nsP1 palmitoylation-
deficient mutants was to use these constructs to obtain novel vectors with pro-
longed transgene expression. Accordingly, an experiment to analyze the cyto-
toxicity of these replicons in BHK-21 cells was performed. 
In this experiment, mutant replicons with the puromycin acetyl-transferase 
(PAC) gene under the control of a sg promoter were used. This method allows 
the survival of transfected cells to be followed; if the replicon is not cytotoxic 
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and expresses sufficient levels of PAC, then colonies can form in the presence 
of puromycin [235,236]. Hence, both the survival of transfected cells in a 
puromycin-containing medium and their ability to form antibiotic resistant 
colonies were analyzed. The phenotypes of all mutant replicons, except mut3A-
2, were found to be indistinguishable from the wt replicon, indicating that their 
cytotoxicity was not reduced (II, Fig. 2). In addition, no colonies were formed 
with mut3A-2, and the transfected cells died rapidly in the presence of puromy-
cin. This result indicates that the cells transfected with this mutant were unable 
to express PAC at levels sufficient to protect them from puromycin. Addition-
ally, RT-PCR coupled with sequencing confirmed the presence of the replicon 
with the proper combination of mutations and the PAC sequence in the trans-
fected cells. The reasons for these properties of SFV1- mut3A-2 are therefore 
not clear, especially considering that this effect was not observed in experi-
ments with the SFV1-enhRlucmut3A-2 replicon (II, Fig. 1). The only expla-
nation that could be provided is that the combination of the 3A-2 mutation and 
the PAC gene influences the three-dimensional structure of the replicon RNA 
such that the translation of the ns-polyprotein and/or the transcription of sg 
RNA is hindered. Taken together, the mutant replicons designed in this study 
were not suitable vector candidates for prolonged gene expression. 
 
 
3.2.3 The effect of mutations on viral infection in different cell lines 
In a previous study (I), only the viability of the mutant viruses and their basic 
growth characteristics were analyzed. Here all mutant viruses with compensa-
tory mutations in their nsP1 coding regions were confirmed to be viable and 
replicated to high titers in both mammalian and mosquito cell lines (II, Table 2). 
Although the differences in Rluc expression levels observed in the replicon 
amplification experiments were vast (II, Fig. 1), the differences in viral titers 
were relatively minor; no greater than a 5- to 50-fold decrease in virion produc-
tion (compared to wt SFV4) was observed for any mutant. For most of the con-
structs, the titers obtained in mammalian cells and insect cells were similar; 
however, the SFV4mut3A-1, SFV4mut3A-3 and SFV43-2 constructs pro-
duced less infectious progeny in insect cells. This result indicates the existence 
of a mild host-specific defect in these mutants. 
To determine whether mutations in the nsP1 coding region affect the ability 
of the virus to activate its protein synthesis and suppress the protein synthesis of 
the host, metabolic labeling experiments were carried out. BHK-21 cells were 
infected at an MOI 10 to obtain simultaneous infection of all cells and pulse-
labeled every hour from 3 to 10 h p.i. The wt SFV4 infection resulted in inten-
sive synthesis of viral structural proteins at 6 h p.i. and was followed by a grad-
ual decrease in cellular protein expression levels (II, Fig. 3). The onset of 
structural protein synthesis in cells infected with any of the nsP1 pal-
mitoylation-deficient viruses, except SFV43-1, was delayed by one hour; 
SFV43-1 began synthesizing viral structural proteins two to three hours later 
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than wt SFV4 (II, Fig. 3). All mutant viruses produced considerably less struc-
tural proteins when compared to the wt virus. The lowest level of structural 
proteins was detected for SFV43-1. This result correlates well with the finding 
that this mutant produces the lowest levels of infectious virus in BHK-21 cells 
(II, Table 2) and suggests that the lower yield of virus particles is most likely 
due to the decreased synthesis of structural proteins in this mutant. 
 
 
3.2.4 Effect of the mutations on viral RNA synthesis 
In addition to the availability of structural proteins, virion production depends 
on many other factors including the production of genomic RNA. Therefore, the 
synthesis of viral positive-strand RNAs in BHK-21 and C6/36 cells was ana-
lyzed using northern blotting. 
Major differences in the viral RNA synthesis levels were revealed between 
different nsP1 palmitoylation-deficient viruses and the wt SFV4 in BHK-21 
cells. The SFV4-3-1 virus that produced the lowest levels of infectious virus 
(II, Table 2) also had the lowest rate of RNA production; the defect was most 
evident at 6 h p.i. (II, Fig. 4a). SFV4-3-2 had the highest RNA synthesis levels 
among the analyzed mutants. Although the RNA levels of SFV4-3-2 were 
diminished at 6 h p.i, they were comparable to the RNA levels of wt SFV4 at 12 
h p.i. Because SFV4-3-2 was one of the constructs that produced the lowest 
amount of infectious virus in BHK-21 cells, this finding was unexpected. Thus, 
it can be concluded that the low virion production was not a result of impaired 
RNA synthesis. Indeed, it has been recently shown that the levels of viral 
RNAs, the amount of synthesized structural proteins and the viral titers do not 
necessarily correlate with each other in VEEV mutants [237]. Nevertheless, the 
delay in structural protein synthesis observed for the mutant viruses in BHK-21 
cells correlates reasonably well with the delayed genomic and sg RNA synthesis 
(II, Fig. 3 and 4a). 
In C6/36 cells, the analysis of viral RNA synthesis was conducted at both the 
permissive and restrictive temperatures. At the permissive temperature, all vi-
ruses replicated efficiently, and only minor delays and reductions in genomic 
RNA synthesis levels could be detected at 48 h, a time point that has been re-
ported to correspond to the onset of persistent infection [26] (II, Fig. 4b). Nota-
bly, however, all mutant viruses produced considerably less sg RNA (II, Table 
3); this finding correlates well with the observed reduction of Rluc expression 
in the replicon experiment (Rluc is also expressed from mRNA synthesized 
using the sg promoter; II, Fig. 1). Interestingly, the presence of numerous RNAs 
with sizes shorter than the sg RNA was observed in C6/36 cells infected with 
the mutant viruses. These RNAs clearly represented DI RNA molecules. The 
emergence of DI RNAs in alphavirus-infected mosquito cells has been observed 
previously [238]; however, their abundance and the speed of their appearance 
(during a single round of infection) in this experiment indicate that their pro-
duction was enhanced by mutations in the nsP1 coding region. At the restrictive 
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temperature, all tested viruses exhibited low levels of RNA synthesis with 
maximum levels of genomic RNA detected at 48 h p.i. (II, Fig. 4c). Abundant 
DI RNAs were detected at this temperature as well. 
The existence of DI RNA molecules, combined with the finding that sg RNA 
production in insect cells is strongly affected, suggests that the interaction of the 
mutant replicase and the cis-acting elements in the virus genome was altered. 
Although the compensatory mutations restored the interactions between nsP1 
and nsP4 in mammalian cells (I, Fig. 6), this result may not occur in insect cells. 
Therefore, additional passaging of mutant viruses in insect cells may be re-
quired to detect mutations that are specifically required for the efficient replica-
tion of nsP1 palmitoylation-deficient viruses in these cells. 
3.2.5 Mutant nsP1 expression in mammalian and insect cells 
The nsP1 expression levels in BHK-21 cells infected with the mutant viruses 
were similar to the nsP1 levels in cells infected with wt SFV4 (II, Fig. 5a). In 
infected insect cells, the amounts of expressed nsP1 were always relatively 
lower than in BHK-21 cells; however, the protein levels observed in cells in-
fected with the mutant and wt SFV4 were similar (II, Fig. 5b). 
In transfected mammalian cells, the defect in nsP1 palmitoylation disrupted 
the formation of filopodia-like extensions and directed nsP1 to localize intra-
cellularly. Most second-site mutations restored the binding of nsP1 to the 
plasma membrane and the formation of filopodia (I, Fig. 5). In insect cells, wt 
and mutant nsP1s also localized to the plasma membrane, but mut3A-nsP1 and 
3-nsP1 were additionally found to localize in the cytoplasm (II, Fig. 6). No 
diversities in localization were detected at different temperatures. Importantly, 
within the same insect cell culture that was transfected with the same expression 
plasmid encoding one mutant type of nsP1, nsP1 positive cells with and without 
filopodia-like structures were detected. Furthermore, the introduced compensa-
tory mutations did not result in an increase in the number of filopodia-contain-
ing cells (II, Fig. 6). Filopodia-like structures that differed slightly in appear-
ance from nsP1-induced filopodia were also found on the mock-transfected 
control cells. Thus, the formation of these structures is likely an intrinsic prop-
erty of C6/36 cells. Because the cell cultures used in these experiments were not 
synchronized, this result may reflect the different behaviours of cells in distinct 
cell cycle stages. Although viral proteins produced in insect cells can be pal-
mitoylated [88], neither the wt nsP1 nor the mutants were tested for their pal-
mitoylation properties. Therefore, the ability of nsP1 to induce filopodia-like 
structures in insect cells cannot be clearly associated with the palmitoylation of 
the protein. 
When expressed as a part of the P123 polyprotein, the intracellular localiza-
tion of nsP1 changes; the localization is no longer exclusive to the plasma 
membrane, and a significant amount of nsP1 is found in intracellular vesicles 
[117]. These structures also contain other replicase proteins. It was found that in 
BHK-21 cells transfected with the P123 expression construct, all pal-
mitoylation-deficient nsP1s co-localized with nsP3 at the perinuclear region (II, 
Fig. 7a). In mosquito cells, the co-localization of nsP1 and nsP3 in vesicles was 
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less apparent (II, Fig. 7b), most likely because of intrinsic differences in CPV 
formation in infected mosquito cells [162]. Taken together, these results indi-
cate that the basic components of the replicase complexes (nsP1-nsP3) 
containing the palmitoylation-deficient nsP1 forms localized correctly in trans-
fected cells. 
To summarize, it can be concluded that in most cases the compensatory mu-
tations found in BHK-21 cells enhanced virus production in mosquito cells as 
well, although the effect tended to be less pronounced than in mammalian cells. 
In insect cells, the viruses containing the corresponding mutations synthesized 
sg RNA at significantly lower levels than wt SFV and were prone to produce 
rapidly large amounts of DI RNAs. This result can be attributed to the altered 
interactions between the mutant replicase and the cis-acting elements of the 
SFV genome but not to the incorrect localization of the mutant replicase pro-
teins and their complexes in insect cells. 
An issue that these studies failed to resolve is the real biological significance 
of nsP1 palmitoylation and the reasons for its appearance in alphavirus evolu-
tion. The analysis of a SINV nsP1 palmitoylation-deficient mutant indicated 
that nsP1 palmitoylation is less important for this virus than for SFV [118,122]. 
In mammalian cells, the virus can survive without palmitoylation, and tighter 
membrane association appears to be dispensable for the virus. These experi-
ments were performed exclusively in BHK-21 cells, which lack a functional 
interferon system. As another set of mutant SFV viruses behaved quite differ-
ently in an IFN-competent system (III), the behaviour of nsP1 palmitoylation-
deficient viruses in other cell lines may have been quite different. However, the 
corresponding experiments were not performed in this study and no supposi-
tions can be made. 
Another interesting property associated with nsP1 palmitoylation is the in-
duction of filopodia-like structures. This function was also restored by all but 
one (mut3A-2) of the compensatory mutations. Interestingly, the replicon con-
taining the mut3A-2 mutation was also the only mutation that was unable to 
provide puromycin resistance (II, Fig. 2); therefore, the possible connection 
between these effects should be investigated. It is also possible that the ability 
to induce the filopodia-like structure is relevant primarily for in vivo infection. 
Previous work has suggested or shown (unpublished results from our research 
group) that alphaviruses can infect cells using other pathways in addition to the 
infection with virions. The formation of filopodia could mediate the cell-to-cell 
spreading of viral genomic material. Similar pathways have also been noted for 
other viruses, although the functioning of these pathways is generally poorly 
understood. For example, the hepatitis C virus can spread from cell to cell with-
out virion formation [239]. The obvious advantages of this mechanism are the 
possibility to spread in the presence of neutralizing antibodies and to infect cells 
lacking suitable receptors for the binding of mature virions. 
The presence of nsP1 on the filopodia-like structures may serve to modulate 
the immune response of the host. This idea has been suggested for CHIKV, 
which mediates the production of auto-immune antibodies and causes symp-
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toms similar to rheumatoid arthritis [240]. Because nsP1 is located on the 
plasma membrane, nsP1 can cause the re-localization of host components by 
binding to the proteins normally found in other cellular compartments. If this re-
localization results in their presence in the incorrect cellular location, it can 
trigger an immune response against these cells. It has been shown that SFV-
induced CPVs contain increased amounts of antigens, such as different heterol-
ogous nuclear ribonucleoproteins that are normally present in the nuclei of cells 
[241]. Filopodia-like structures and their possible ability to mediate the secre-
tion of replicase-containing vesicles would certainly enhance the presentation of 
such proteins. Further research involving in vivo experiments and the analysis 
of clinical samples from patients with chronic symptoms of CHIKV infection is 
needed to address these questions. 
 
 
3.3 Alphavirus replication and interactions with the host 
innate immunity are regulated by the processing of the 
1/2 cleavage site (III, unpublished) 
The expression and correct processing of the alphavirus ns-polyprotein is es-
sential for the viability of the virus. The production of free nsP4, either by pro-
cessing the 3/4 cleavage site (natural expression) or in trans (in this case, the 
co-expression of P123 is also required), represents an absolute requirement for 
active replication complex formation [18,163]. If free nsP4 is not formed, no 
replication can be observed. However, the requirements for processing the re-
maining P123 are less strict. The virus can survive a significant delay in the 
processing of any of the two remaining cleavage sites (III, [141] or a complete 
blockage of the sites (III, [174]. On the other hand, the acceleration of cleavage 
with a hyper-activated nsP2 protease, has been reported to be lethal for SINV 
[242]. Manipulating the cleavage efficiency at the 2/3 site has little or no effect 
on alphavirus infectivity [15,141], III) and therefore the infectivity was thought 
to be controlled by the cleavage of the 1/2 site. It is known that the 1/2 site can 
be cleaved in trans by nsP2, but the efficiency is approximately 5000-fold lower 
than the processing of the 3/4 site [140]. Therefore, most of the 1/2 cleavages in 
infected cells and in vitro occur in cis [16,138]. Processing of the 1/2 site is also 
absolutely required for the subsequent processing of the 2/3 site [141], and 
differences in the processing speed of the 1/2 site have been shown to influence 
SINV neurovirulence in mice [243]. 
Thus, the 1/2 cleavage controls, at least in part, the stability of P123. What is 
more, the stability of P123 is an important determinant in the correct subcellular 
localization of alphaviral replicase complexes [117], ensuring that all replicase 
components are transported together to the plasma membrane, where replication 
complex formation occurs [162,163]. Thus, it can be assumed that all these 
processes are directly controlled by the cleavage of the 1/2 site. 
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3.3.1 Mutations accelerating 1/2 cleavage are detrimental for SFV 
replicase complex formation and for the infectivity of the 
corresponding recombinant genomes (unpublished) 
Previous studies have identified the Arg residue at the P4 position in the 3/4 
cleavage site (the 4th amino acid residue preceding the scissile bond in the 
cleavage site) as the major determinant for efficient processing of the site [15]. 
In the 1/2 cleavage site in SFV4, this position is occupied by a His residue (III, 
Fig. 2), but an Arg residue is retained in the A7/74 isolate of SFV [10]. Because 
both isolates are viable, this observation led to the hypothesis that the P4 resi-
due in the 1/2 cleavage site cannot be the only determinant, and may not even 
be the decisive one, for its processing. Therefore, to artificially accelerate the 
cleavage event at this site, the native cleavage site with the sequence 
EYHAG531A was substituted with LGRAG531A, which is the sequence naturally 
occurring in the most actively cleaved 3/4 processing site of SFV4. It was found 
that the infectivity of the obtained recombinant RNA transcripts decreased 
drastically by almost 10,000-fold when compared to wt SFV4. Nevertheless, 
similarily to the nsP1 palmitoylation-deficient mutants (I), infectious progeny 
with growth characteristics relatively similar to wt SFV4 was obtained. Se-
quence analysis of these viruses revealed that the majority of the viruses had 
either reverted the P4 Arg residue to the native His residue or substituted it with 
Cys, Leu or Ser residues. All these substitutions significantly slowed down the 
accelerated processing of the P123 polyprotein, indicating that this change was 
the key defect caused by the LGRAG531A mutation. Furthermore, another com-
pensatory mutation that compensated for the defect caused by the LGRAG531A 
mutation was identified in the protease part of nsP2. The properties of the corre-
sponding mutants are currently under detailed analysis using in vitro and in vivo 
experiments. However, based on the presented data, it is clear that the delayed 
cleavage of the 1/2 cleavage site is crucial for viral replicase complex formation 
and virus infectivity. 
 
 
3.3.2 The P5 residue controls the processing  
of the 1/2 cleavage site 
The data presented above clearly indicate that the introduction of an Arg residue 
into the P4 position of the 1/2 site can accelerate its processing. However, this 
result does not indicate that this residue is the major determinant in controlling 
this cleavage event. While the mutant with the LGRAG531A residues could only 
survive due to the accumulation of various adaptive mutations, the SFV A7 
isolate is viable (P4 Arg) on its own. Thus, it is likely that other residues are 
also important for controlling the processing of the 1/2 site. 
To highlight the importance of these aa residues in P1234 processing, the 
residues in LG528R (P6-P4) were substituted with Ala residues (III, Fig. 2a). The 
corresponding single Ala substitutions were introduced into a construct de-
signed for in vitro transcription and translation analyses; a construct in which all 
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three residues in the P6-P4 region (527-529) were substituted with Ala residues 
was also generated. This triple mutation was introduced into the DNA clone of 
SFV4 [187]; a construct with similar substitutions at other cleavage sites was 
also generated. 
Using an in vitro transcription and translation system, it was found that the 
introduction of an Ala residue in the P5 position of the 1/2 cleavage site resulted 
in increased amounts of several cleavage intermediates, especially P12. Corre-
spondingly, a decrease in the amounts of mature ns-proteins was observed (III, 
Fig. 1a). The same result was also observed for the triple AA528A mutant, but 
not for mutant polyproteins containing only the P4 Ala or P6 Ala substitutions. 
Thus, it was confirmed that the P5 position in the 1/2 cleavage site represents 
the major determinant for directing the release of nsP1. 
 
 
3.3.3. Mutations in all cleavage sites reduce the  
infectivity of recombinant genomes 
The transcripts of icDNA clones with a triple Ala mutation in the 1/2 cleavage 
site were highly infectious. Thus, in contrast to the cleavage accelerating LGR 
mutation in the 1/2 site, the mutation that decreased the cleavage rate (AAA) 
had little or no effect on the infectivity of the virus (III, Fig. 2b). Furthermore, 
the overall growth kinetics of the rescued virus resembled wt SFV4 (III, Fig. 3); 
the reduced plaque size of the mutant SFV4-1AAA virus was the only differ-
ence that could be detected. Consistent with the high infectivity of the mutant 
genome and efficient propagation of the corresponding virus, no reversions, 
pseudoreversions or common second-site mutations were detected in SFV4-
1AAA infected cells. However, a drastic decrease in infectivity (more than 
1000-fold) was observed when a RNA transcript of a construct containing three 
similarly mutated cleavage sites (SFV4-3xAAA) was analyzed. This effect 
cannot be attributed to mutations in any specific cleavage site because mutant 
genomes having three Ala residues in the 2/3 or 3/4 cleavage sites (P6-P4 posi-
tions) demonstrated similar infectivity and growth kinetics to wt SFV4. There-
fore, the defect must be attributed to the combination of the 1/2 site mutation 
with other mutations. This combination of mutations not only altered the speed 
and efficiency of the processing of the cleavage sites in P1234 but also altered 
its processing pattern as a whole. SFV4-3xAAA produced minute plaques in 
infected BHK-21 cells and had a decreased rate of virion release (III, Fig. 3). 
However, after the first passage, SFV4-3xAAA was already capable of growing 
to high titers. This behaviour was similar to the viruses with palmitoylation-
deficient forms of nsP1, suggesting that the initial defect must have been com-
pensated by additional mutations. Nevertheless, no reversions or pseudorever-
sions in any of the mutated cleavage sites were observed when the SFV4-
3xAAA virus was passaged five times in BHK-21 cells. Therefore, several indi-
vidual viral clones were obtained using plaque purification techniques. Se-
quencing of these clones revealed a common second-site mutation leading to a 
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Q706R change in the nsP2 protein. When this mutation was introduced into the 
genome of SFV4-3xAAA (the resulting construct was designated as SFV4-
3xAAA-Q706R), the infectivity of the obtained recombinant genome increased 
approximately 100-fold (III, 2b). Thus, the Q706R mutation compensated for 
the defects that arose due to the altered aa composition of the cleavage sites. 
 
 
3.3.4 The effects of combined mutations on polyprotein processing 
The reduced infectivity of SFV4-3xAAA (and the lack of a similar effect in 
mutants with changes in any of the individual cleavage sites) suggested that 
cleavages at different sites affect each other. To verify this effect directly, the 
processing of the mutant P1234 polyprotein containing mutations in all three 
sites was analyzed using an in vitro transcription and translation system. This 
analysis revealed that the levels of all fully processed nsPs were diminished (III, 
Fig. 4). In agreement with this result, the levels of unprocessed polyproteins, 
especially P34, were increased. Importantly, however, the introduction of the 
Q706R mutation modified the cleavage pattern of the mutant polyprotein, which 
now resembled wt P1234. These data suggest that the identified mutation re-
stores the infectivity of the SFV4-3xAAA-Q706R transcripts by altering the 
processing of the mutant ns-polyprotein. The same analysis was also conducted 
in BHK-21 cells using a pulse-chase method. Because SFV4-3xAAA was ge-
netically unstable, the analysis of P1234-3xAAA polyprotein processing with-
out the Q706R mutation in virus-infected cells was not possible. The ns-poly-
protein processing patterns of SFV4-3xAAA viruses with the compensatory 
Q706R mutation were found to closely resemble wt SFV4; the only detectable 
difference was the increased stability of P123 in cells infected with the mutant 
viruses (III, Fig. 5b). Thus, the differences in the ns-polyprotein processing 
pattern observed in the test tube reaction were clearly reproduced in the context 
of viral infection as well. 
 
 
3.3.5 Mutations in the P1234 processing sites restrict  
replication or rescued the virus in many cell lines 
To estimate whether the compensatory changes obtained in BHK-21 cells were 
cell type-specific, the two plaque-purified isolates of SFV4-3xAAA (containing 
the common Q706R mutation) and the rescued SFV4-3xAAA-Q706R virus 
were used to infect other cell types. The productive infection of C6/36 cells 
with the mutant viruses was not possible, suggesting that the defects resulting 
from mutations had more severe effect(s) in mosquito cells. In contrast, efficient 
replication was observed in the human hepatocyte carcinoma Huh7 cell line. It 
can be therefore concluded that the compensatory changes are not strictly BHK-
21-specific. 
It was observed that in several cells lines, including the human HS633T fi-
broblast cell line, the SFV4-3xAAA-Q706R viruses replicated very poorly. 
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First, these cells are naturally less susceptible to SFV4 infection compared to 
BHK-21 cells; at least five-fold more wt SFV4 was needed to achieve the same 
level of infected cells. Furthermore, even at an MOI of 5, no more than 95% of 
the HS633T cells could be infected. Nevertheless, these effects could not ex-
plain the defect of SFV4-3xAAA-Q706R viruses because the wt SFV4 was 
capable of performing productive infection in these cells. However, the defects 
in establishing an infection was larger for mutant viruses; as little as 30-40% of 
the cells were infected using an MOI of 5. However, all mutant viruses were 
capable of replicating in HS633T cells, and the CPVs containing the SFV repli-
case complexes that are produced by the mutant viruses were even larger than 
those induced by a wt SFV4 infection (III, Fig. 6). Thus, AAA mutations in the 
cleavage sites (compensated by a Q706R change) had little effect on the for-
mation of replication-associated structures in these cells. In contrast, the mor-
phology of the CPVs was altered for a SFV mutant that expressed the uncleava-
ble P123 (an E452A mutation was introduced into nsP4 to obtain higher levels 
of the virus as described in [174]). In this mutant, very small CPVs were ob-
served.  
 
 
3.3.6 The effect of cleavage site mutations on interferon production 
The HS633T cell line has an intact interferon system [244]. Therefore, an infec-
tion in these cells mimics some aspects of the innate immune responses trig-
gered in animals infected with alphaviruses. Growth curves of viruses obtained 
using these cells indicated that none of the constructed mutants were able to 
produce more infectious virions than was used to infect them (III, Fig. 7a). In 
cells infected with SFV4-123-E452A ( represents a blocked cleavage site), a 
steady decline in the virus titer was observed, most likely indicating the lack of 
release of infectious progeny. In cells infected with SFV4-23 (another control 
virus used in this experiment) or with any of the SFV4-3xAAA-Q706R viruses, 
low amounts of viral progeny were produced. Cytotoxic effects, characteristic 
for wt SFV4 infection at 24 h p.i., were only observed in the SFV4-23-infected 
cells. Thus, in the presence of an IFN response, the SFV4-3xAAA-Q706R vi-
ruses failed to produce large amounts of progeny, and the infection was cleared, 
most probably by the innate immune response. 
Thus, the introduced mutations likely caused a defect in the ability of SFV to 
suppress the IFN response. To verify this hypothesis directly, the release of 
IFN/ into the growth medium of infected cells was analyzed. It turned out 
that the SFV4-123-E452A-infected cells produced the highest amounts of 
IFN, beginning as early as 4 h p.i. (III, Fig. 7b). This result is in agreement with 
the data observed for a SINV mutant with a similar design [174] and is thought 
to result from the inability of the uncleaved P123 to enter the nucleus and pre-
vent the transcription of IFN genes. In contrast, the IFN release from wt SFV4-
infected cells was negligible at 8 h p.i. Again, this result was expected because 
wt SFV4 has been shown to efficiently suppress type I IFN production [128]. 
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After 8 hours, the production of type I interferon began to increase in wt SFV4-
infected cell cultures; this production continued until the excessive death of the 
infected cell culture. The SFV4-3xAAA and SFV4-3xAAA-Q706R clones 
displayed an intermediate phenotype in IFN production. For cells infected with 
these viruses, IFN expression was detected at 8 h p.i.; however, high levels of 
IFN were not reached. The same result was observed in a parallel experiment 
designed to assess the influence of newly produced mutant virions on IFN pro-
duction (in this experiment, the growth medium was not substituted with fresh 
medium, and only aliquots were collected). These data indicate that unlike wt 
SFV4, the SFV4-3xAAA and SFV4-3xAAA-Q706R viruses cannot suppress 
IFN induction and signaling efficiently enough. However, the defect in sup-
pressing IFN production was not nearly as profound as in SFV4-123-E452A. 
The latter virus could not produce any free nsP2 and expressed exclusively 
P123. In contrast, in BHK-21 cells, no delay in nsP2 release was detected for 
SFV4-3xAAA viruses (III, Fig. 5B). If the same result would also be true for 
HS633T cells, then the most likely reason for a high level of IFN induction 
(compared to wt SFV4) might be in the Q706R mutation in nsP2 that can re-
duce its functioning in reducing IFN expression. The prolonged production of 
P123 might also result in the synthesis of excessive amounts of dsRNA. To 
distinguish between these possibilities, additional experiments would be 
needed. However, the data obtained in this study indicate that the IFN response 
has an important role in limiting the infection of SFV4-3xAAA and may limit 
the spread of such viruses in an organism. This hypothesis corresponds to pre-
vious observations made using SINV; these studies have shown that a mutation 
in the 1/2 cleavage site is one of the main determinants of its virulency and that 
the introduction of this mutation induced a high level of IFN production [245]. 
To test this hypothesis, in vivo experiments using different SFV strains, espe-
cially the most neurovirulent L10 strain engineered to contain cleavage site 
mutations, need to be performed. 
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SUMMARY 
NsP1 is an essential component of the alphavirus replicase. Among other func-
tions, nsP1 is involved in regulating the formation of a replicase complex and 
attaching the complex to host cell membranes. 
The analysis of Semliki Forest virus (SFV) mutants with different pal-
mitoylation-deficient versions of nsP1 in BHK-21 cells revealed that, in gen-
eral, the mutant genomes had severely reduced infectivities. Some of the corre-
sponding viruses had a temperature-sensitive phenotype. The main defect 
caused by most but not all mutations in the nsP1 palmitoylation site was disrup-
tion of the interactions between nsP1 and nsP4. This defect was rescued by 
second-site compensatory mutations identified in nsP1-encoding sequences in 
the plaque-purified isolates of rescued viruses. These mutations also led to the 
increased infectivity of the corresponding RNA genomes. In general, this effect 
was also observed in insect C6/36 cells, albeit to a lesser extent. In these cells, 
the impact of the original mutation on virus infection was more prominent, and 
the most affected step of virus infection was the production of subgenomic 
RNA (sg RNA). The second-site mutations had little effect on the sg RNA pro-
duction defect in C6/36 cells. Instead, the mutant viruses triggered the for-
mation of a large number of defective interfering genomes in insect cells. 
Therefore, it was proposed that in C6/36 cells, the mutations in the pal-
mitoylation site of nsP1 also disrupted the connections between cis-acting ele-
ments of the viral genome and the replicase proteins, and this defect could not 
be restored by the second-site mutations selected in mammalian cells. The for-
mation of filopodia-like structures, characteristic of vertebrate cells infected 
with wt SFV, was also affected by nsP1 mutations. Most of the identified com-
pensatory mutations were found to contribute to the restoration of the formation 
of these structures. The filopodia-like structures were thought to be involved in 
the cell-to-cell spreading of the infection.  
The analysis of the processing requirements of the 1/2 cleavage site in the 
SFV ns-polyprotein highlighted its importance as one of the major regulatory 
factors controlling the assembly of a functional replication complex. It was 
shown that the accelerated processing of this site severely diminished the infec-
tivity of the corresponding mutant genome, while a reduction in the cleavage 
efficiency had only a minor effect. The processing of the 1/2 site depends 
mostly on the amino acid residue in the P5 position. The processing of the 1/2 
site was slowed when the original P5 residue was replaced with an Ala residue. 
When this mutation was combined with mutations that reduce the cleavage 
efficiency in the 2/3 and 3/4 sites, the resulting virus genome had reduced in-
fectivity and became genetically unstable. However, the defects in all three 
cleavages were efficiently rescued by a single second-site mutation (Q706R) in 
the nsP2 coding region. The resulting viruses were incapable of replicating in 
C6/36 cells and poorly infected cells with an intact IFN system. It was sug-
gested that the prolonged expression of P123 that results from the mutation in 
the P5 position in the 1/2 cleavage site and the Q706R mutation in the nsP2 
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coding region contributes to the enhanced type I IFN production in these cells. 
Detailed studies using animal models are required to provide further infor-
mation about the biological implications of these findings. 
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SUMMARY IN ESTONIAN  
Semliki Forest viiruse replikaasivalgu nsP1 uurimine 
 
Semliki Forest viirus (SFV) kuulub alfaviiruste perekonda sugukonnas Toga-
viridae. Alfaviirused on olulised patogeenid ning põhjustavad erinevaid vaevusi 
ka inimestele. Levik looduses toimub sääskede vahendusel. Lisaks tähtsusele 
patogeensuse tõttu on alfaviirused kasutusel ka bio- ning geenitehnoloogias 
ning seetõttu olulisteks uurimisobjektideks. Alfaviirustel on positiivse polaar-
susega RNA genoom, millelt transleeritakse viiruse replikaasi subühikud (nsP1-
nsP4). Antud töö põhiline uurimisobjekt nsP1 vastutab lisaks otsesele osale-
misele replikatsioonil ja transkriptsioonil replikaasi sidumise eest peremeesraku 
membraanidele. 
Käesolevas uurimistöös analüüsiti SFV mutante, mille nsP1 valku kodeerivat 
ala oli muudetud nii, et sünteesitavat valku rakkudes ei palmitüleerita. Kasu-
tades imetajate rakke (BHK-21) leiti, et selliste viiruste genoomide infektsiooni-
lisus oli järsult vähenenud ja osadel saadud viirustel oli temperatuuritundlik 
fenotüüp. Põhiline funktsionaalne defekt, mis kaasnes enamike mutatsioonidega 
nsP1 palmitüleerimise saidis, oli nsP1 ja nsP4 vaheliste kontaktide puudumine. 
Kasutades vabanenud viiruste plaag-puhastamist ja sekveneerimist selgitati väl-
ja, et viiruste infektsioonilisuse taastamise põhjuseks olid mutatsioonid, mis 
võimaldasid mutantsel nsP1 seonduda nsP4 valguga. Näidati, et sellised sekun-
daarsed mutatsioonid tõstsid oluliselt vastavate RNA genoomide infektsiooni-
lisust BHK-21 rakkudes.  
Üldjoontes esinesid sarnased efektid, ehkki vähemal määral, ka putukast 
pärinevates C6/36 rakkudes. Nendes rakkudes olid esialgsete mutatsioonide 
poolt põhjustatud defektid viiruse paljunemise juures suuremad kui imetaja 
rakuliinis. Kõige suuremaks efektiks oli subgenoomse RNA tootmise vähene-
mine. Kompensatoorsed mutatsioonid suurendasid viiruse infektsioonilisust 
C6/36 rakkudes väiksemal määral kui imetajate rakkudes ning tekkis suur hulk 
defektseid interfereeruvaid RNA genoome. Seetõttu võib oletada, et nsP1 
palmitüleerimissaidi mutatsioonid takistavad C6/36 rakkudes viiruse genoomi 
cis-elementide ja replikaasivalkude vahelisi interaktsioone. Ilmselt osalevad 
nendes interaktsioonides ka raku valgud, mistõttu imetaja rakkudes paljunda-
misel tekkivad sekundaarsed mutatsioonid ei suuda putuka rakkudes tekkivaid 
defekte kompenseerida.  
Lisaks leiti, et nsP1 palmitüleerimise puudumine takistab filopoodiumi-laad-
sete struktuuride moodustamist nakatatud rakkude plasmamembraanil. Tuvas-
tati, et suurem osa analüüsitud kompensatoorsetest mutatsioonidest taastab 
vähemalt osaliselt viiruse võime selliseid struktuure moodustada. Sellest läh-
tudes pakuti välja hüpotees, mille kohaselt filopoodiumi-laadsed moodustised 
aitavad kaasa viirusinfektsiooni levimisele rakust rakku.  
Mittestruktuurse polüproteiini 1/2 lõikesaidi analüüs näitas, et selle saidi 
lõikamine õigel ajal on üks olulisematest regulatoorsetest etappidest funktsio-
naalse replikaaskompleksi moodustumisel. Näidati, et 1/2 saidi lõikamise 
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kiirendamine vähendas olulisel määral vastavate mutantsete genoomide infekt-
sioonilisust sama ajal kui lõikamise aeglustamisel oli väiksem mõju. Leiti, et 
1/2 saidi lõikamine sõltub eriti tugevalt lõikesaidi P5 positsioonis asuvast 
aminohappejäägist. Selles positsioonis oleva aminohappejäägi asendamine ala-
niini jäägiga aeglustus liitvalgu lõikamise kiirust, kuid ei muutnud rekombi-
nantse viiruse genoomi infektsioonilisust. Viiruse genoom, kuhu lisaks mutat-
sioonidele 1/2 lõikesaidis oli sisse viidud ka lõikamist takistavad mutatsioonid 
2/3 ja 3/4 saitides, oli aga oluliselt vähenenud infektsioonilisusega ja moodus-
tatud viirus oli geneetiliselt ebastabiilne. Leiti et kõiki sisse viidud defekte saab 
kompenseerida ühe täiendava mutatsiooniga (Q706R) nsP2 kodeerivas piir-
konnas, mis taastas viiruse elujõulisuse ja liitvalgu korrektse lõikamise BHK-21 
rakkudes. Samas ei suutnud selline viirus paljuneda C6/36 rakkudes ning tema 
paljunemine oli takistatud ka terviklikku interferoonvastust omavates imetaja-
rakkudes. Nendest tulemustes lähtuvalt pakuti välja hüpotees, mille kohaselt 
mutatsioonid 1/2 lõikesaidis ja nsP2 valgus põhjustavad viiruse P123 liitvalgu 
eluea pikenemise, mis takistab viirusel võimet I tüüpi interferoonide tootmist 
efektiivselt blokeerida. Uuritud mutatsioonide bioloogiliste efektide põhjaliku-
maks uurimiseks on tarvis läbi viia loomkatseid. 
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